CN110343650B - Recombinant streptomyces tuberculatus for producing amphotericin B and application thereof - Google Patents
Recombinant streptomyces tuberculatus for producing amphotericin B and application thereof Download PDFInfo
- Publication number
- CN110343650B CN110343650B CN201910451258.6A CN201910451258A CN110343650B CN 110343650 B CN110343650 B CN 110343650B CN 201910451258 A CN201910451258 A CN 201910451258A CN 110343650 B CN110343650 B CN 110343650B
- Authority
- CN
- China
- Prior art keywords
- amphotericin
- seq
- fermentation
- streptomyces
- recombinant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 title claims abstract description 69
- 229960003942 amphotericin b Drugs 0.000 title claims abstract description 67
- APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 title claims abstract description 66
- 241000187747 Streptomyces Species 0.000 title claims abstract description 32
- 241000916757 Tuberculatus Species 0.000 title claims abstract description 22
- 238000000855 fermentation Methods 0.000 claims abstract description 51
- 230000004151 fermentation Effects 0.000 claims abstract description 51
- 241000122969 Streptomyces nodosus Species 0.000 claims abstract description 38
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 30
- MZFOKIKEPGUZEN-AGCMQPJKSA-N (R)-methylmalonyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)[C@@H](C(O)=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 MZFOKIKEPGUZEN-AGCMQPJKSA-N 0.000 claims abstract description 3
- QGGFZZLFKABGNL-UHFFFAOYSA-N Amphotericin A Natural products OC1C(N)C(O)C(C)OC1OC1C=CC=CC=CC=CCCC=CC=CC(C)C(O)C(C)C(C)OC(=O)CC(O)CC(O)CCC(O)C(O)CC(O)CC(O)(CC(O)C2C(O)=O)OC2C1 QGGFZZLFKABGNL-UHFFFAOYSA-N 0.000 claims abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 56
- 239000002609 medium Substances 0.000 claims description 32
- 239000001963 growth medium Substances 0.000 claims description 26
- 239000000843 powder Substances 0.000 claims description 25
- 239000006228 supernatant Substances 0.000 claims description 25
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 22
- 239000000725 suspension Substances 0.000 claims description 22
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 20
- 239000007788 liquid Substances 0.000 claims description 17
- 229920000742 Cotton Polymers 0.000 claims description 16
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 15
- 239000008223 sterile water Substances 0.000 claims description 15
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 14
- 239000008103 glucose Substances 0.000 claims description 14
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 13
- 238000012258 culturing Methods 0.000 claims description 11
- 239000001888 Peptone Substances 0.000 claims description 10
- 108010080698 Peptones Proteins 0.000 claims description 10
- 235000019319 peptone Nutrition 0.000 claims description 10
- 238000011218 seed culture Methods 0.000 claims description 10
- 239000011780 sodium chloride Substances 0.000 claims description 10
- 229920001817 Agar Polymers 0.000 claims description 8
- 239000008272 agar Substances 0.000 claims description 8
- 238000001914 filtration Methods 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 8
- 108010016219 Acetyl-CoA carboxylase Proteins 0.000 claims description 7
- 102000000452 Acetyl-CoA carboxylase Human genes 0.000 claims description 7
- 101150084750 1 gene Proteins 0.000 claims description 5
- 101150028074 2 gene Proteins 0.000 claims description 5
- 108010030975 Polyketide Synthases Proteins 0.000 claims description 5
- 108090000769 Isomerases Proteins 0.000 claims description 4
- 239000007836 KH2PO4 Substances 0.000 claims description 4
- 108010073771 Soybean Proteins Proteins 0.000 claims description 4
- 235000015278 beef Nutrition 0.000 claims description 4
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 4
- 235000019710 soybean protein Nutrition 0.000 claims description 4
- 101001126977 Homo sapiens Methylmalonyl-CoA mutase, mitochondrial Proteins 0.000 claims description 3
- 101150081455 PKS5 gene Proteins 0.000 claims description 3
- 238000005273 aeration Methods 0.000 claims description 3
- 239000002054 inoculum Substances 0.000 claims description 2
- 238000009630 liquid culture Methods 0.000 claims description 2
- 230000000813 microbial effect Effects 0.000 claims description 2
- 239000002244 precipitate Substances 0.000 claims description 2
- 229930183010 Amphotericin Natural products 0.000 claims 1
- 229940009444 amphotericin Drugs 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 abstract description 9
- 239000002243 precursor Substances 0.000 abstract description 8
- 239000000047 product Substances 0.000 abstract description 7
- 239000000126 substance Substances 0.000 abstract description 5
- 230000002860 competitive effect Effects 0.000 abstract description 4
- 230000002018 overexpression Effects 0.000 abstract description 4
- 238000012795 verification Methods 0.000 abstract description 4
- 235000015097 nutrients Nutrition 0.000 abstract description 3
- QGGFZZLFKABGNL-MOISJGEISA-N (1s,3r,4e,6e,8e,10e,14e,16e,18s,19r,20r,21s,25r,27r,30r,31r,33s,35r,37s,38r)-3-[(2r,3s,4s,5s,6r)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-19,25,27,30,31,33,35,37-octahydroxy-18,20,21-trimethyl-23-oxo-22,39-dioxabicyclo[33.3.1]nonatriaconta-4,6,8,10,14, Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 QGGFZZLFKABGNL-MOISJGEISA-N 0.000 abstract 1
- 229940100228 acetyl coenzyme a Drugs 0.000 abstract 1
- 239000006227 byproduct Substances 0.000 abstract 1
- LTYOQGRJFJAKNA-IJCONWDESA-N malonyl-coenzyme a Chemical compound O[C@@H]1[C@@H](OP(O)(O)=O)[C@H](CO[P@](O)(=O)O[P@@](O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CC(O)=O)O[C@H]1N1C2=NC=NC(N)=C2N=C1 LTYOQGRJFJAKNA-IJCONWDESA-N 0.000 abstract 1
- 239000013598 vector Substances 0.000 description 42
- 239000012634 fragment Substances 0.000 description 30
- 241000588724 Escherichia coli Species 0.000 description 28
- 238000000034 method Methods 0.000 description 28
- 241000894006 Bacteria Species 0.000 description 20
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 18
- 239000013612 plasmid Substances 0.000 description 17
- 238000002360 preparation method Methods 0.000 description 17
- 239000007787 solid Substances 0.000 description 16
- 239000008399 tap water Substances 0.000 description 14
- 235000020679 tap water Nutrition 0.000 description 14
- 230000001954 sterilising effect Effects 0.000 description 13
- 238000010200 validation analysis Methods 0.000 description 13
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 12
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 12
- 238000010367 cloning Methods 0.000 description 12
- 238000004659 sterilization and disinfection Methods 0.000 description 11
- 238000000137 annealing Methods 0.000 description 10
- 239000008367 deionised water Substances 0.000 description 10
- 229910021641 deionized water Inorganic materials 0.000 description 10
- 238000004925 denaturation Methods 0.000 description 10
- 230000036425 denaturation Effects 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 238000011144 upstream manufacturing Methods 0.000 description 9
- 102000012410 DNA Ligases Human genes 0.000 description 8
- 108010061982 DNA Ligases Proteins 0.000 description 8
- 230000003115 biocidal effect Effects 0.000 description 8
- 229930027917 kanamycin Natural products 0.000 description 8
- 229960000318 kanamycin Drugs 0.000 description 8
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 8
- 229930182823 kanamycin A Natural products 0.000 description 8
- 238000012163 sequencing technique Methods 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 238000012546 transfer Methods 0.000 description 8
- 229960000723 ampicillin Drugs 0.000 description 7
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 7
- 230000001580 bacterial effect Effects 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 108020004465 16S ribosomal RNA Proteins 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 238000009835 boiling Methods 0.000 description 6
- 229910001629 magnesium chloride Inorganic materials 0.000 description 6
- 239000002773 nucleotide Substances 0.000 description 6
- 125000003729 nucleotide group Chemical group 0.000 description 6
- 239000008188 pellet Substances 0.000 description 6
- 108010018763 Biotin carboxylase Proteins 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 238000004128 high performance liquid chromatography Methods 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 238000012216 screening Methods 0.000 description 5
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 4
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 4
- 108010005054 Deoxyribonuclease BamHI Proteins 0.000 description 4
- 108010051862 Methylmalonyl-CoA mutase Proteins 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000014509 gene expression Effects 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 239000013600 plasmid vector Substances 0.000 description 4
- 229930000044 secondary metabolite Natural products 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 101100268665 Caenorhabditis elegans acc-1 gene Proteins 0.000 description 3
- 101100268668 Caenorhabditis elegans acc-2 gene Proteins 0.000 description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
- 108050009160 DNA polymerase 1 Proteins 0.000 description 3
- 108010047524 Deoxyribonuclease HindIII Proteins 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 102100031780 Endonuclease Human genes 0.000 description 3
- 108010042407 Endonucleases Proteins 0.000 description 3
- 206010017533 Fungal infection Diseases 0.000 description 3
- 229930195725 Mannitol Natural products 0.000 description 3
- 102000019010 Methylmalonyl-CoA Mutase Human genes 0.000 description 3
- 208000031888 Mycoses Diseases 0.000 description 3
- 241000737052 Naso hexacanthus Species 0.000 description 3
- 108010002747 Pfu DNA polymerase Proteins 0.000 description 3
- 235000019764 Soybean Meal Nutrition 0.000 description 3
- NSFFHOGKXHRQEW-UHFFFAOYSA-N Thiostrepton B Natural products N1C(=O)C(C)NC(=O)C(=C)NC(=O)C(C)NC(=O)C(C(C)CC)NC(C(C2=N3)O)C=CC2=C(C(C)O)C=C3C(=O)OC(C)C(C=2SC=C(N=2)C2N=3)NC(=O)C(N=4)=CSC=4C(C(C)(O)C(C)O)NC(=O)C(N=4)CSC=4C(=CC)NC(=O)C(C(C)O)NC(=O)C(N=4)=CSC=4C21CCC=3C1=NC(C(=O)NC(=C)C(=O)NC(=C)C(N)=O)=CS1 NSFFHOGKXHRQEW-UHFFFAOYSA-N 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 229960005091 chloramphenicol Drugs 0.000 description 3
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 3
- 238000010835 comparative analysis Methods 0.000 description 3
- 230000021615 conjugation Effects 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 239000012043 crude product Substances 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 238000007710 freezing Methods 0.000 description 3
- 230000008014 freezing Effects 0.000 description 3
- 239000003292 glue Substances 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 239000000594 mannitol Substances 0.000 description 3
- 235000010355 mannitol Nutrition 0.000 description 3
- 238000005192 partition Methods 0.000 description 3
- 230000035939 shock Effects 0.000 description 3
- 239000004455 soybean meal Substances 0.000 description 3
- 229930188070 thiostrepton Natural products 0.000 description 3
- 229940063214 thiostrepton Drugs 0.000 description 3
- NSFFHOGKXHRQEW-AIHSUZKVSA-N thiostrepton Chemical compound C([C@]12C=3SC=C(N=3)C(=O)N[C@H](C(=O)NC(/C=3SC[C@@H](N=3)C(=O)N[C@H](C=3SC=C(N=3)C(=O)N[C@H](C=3SC=C(N=3)[C@H]1N=1)[C@@H](C)OC(=O)C3=CC(=C4C=C[C@H]([C@@H](C4=N3)O)N[C@H](C(N[C@@H](C)C(=O)NC(=C)C(=O)N[C@@H](C)C(=O)N2)=O)[C@@H](C)CC)[C@H](C)O)[C@](C)(O)[C@@H](C)O)=C\C)[C@@H](C)O)CC=1C1=NC(C(=O)NC(=C)C(=O)NC(=C)C(N)=O)=CS1 NSFFHOGKXHRQEW-AIHSUZKVSA-N 0.000 description 3
- NSFFHOGKXHRQEW-OFMUQYBVSA-N thiostrepton A Natural products CC[C@H](C)[C@@H]1N[C@@H]2C=Cc3c(cc(nc3[C@H]2O)C(=O)O[C@H](C)[C@@H]4NC(=O)c5csc(n5)[C@@H](NC(=O)[C@H]6CSC(=N6)C(=CC)NC(=O)[C@@H](NC(=O)c7csc(n7)[C@]8(CCC(=N[C@@H]8c9csc4n9)c%10nc(cs%10)C(=O)NC(=C)C(=O)NC(=C)C(=O)N)NC(=O)[C@H](C)NC(=O)C(=C)NC(=O)[C@H](C)NC1=O)[C@@H](C)O)[C@](C)(O)[C@@H](C)O)[C@H](C)O NSFFHOGKXHRQEW-OFMUQYBVSA-N 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 102000004195 Isomerases Human genes 0.000 description 2
- 239000012880 LB liquid culture medium Substances 0.000 description 2
- 108700005078 Synthetic Genes Proteins 0.000 description 2
- 230000000843 anti-fungal effect Effects 0.000 description 2
- 229940121375 antifungal agent Drugs 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- 108091008053 gene clusters Proteins 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- MZFOKIKEPGUZEN-FBMOWMAESA-N methylmalonyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C(C(O)=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 MZFOKIKEPGUZEN-FBMOWMAESA-N 0.000 description 2
- 150000004291 polyenes Chemical class 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 210000002235 sarcomere Anatomy 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- WGAXKIBBLQOPDQ-WXODNCMKSA-N 4-amino-n-[(e,2r,3r,6s)-3-benzyl-2-hydroxy-6-(methanesulfonamido)-7-naphthalen-2-ylsulfinylhept-4-enyl]-n-(2-methylpropyl)benzenesulfonamide Chemical compound C([C@@H]([C@@H](O)CN(CC(C)C)S(=O)(=O)C=1C=CC(N)=CC=1)\C=C\[C@@H](CS(=O)C=1C=C2C=CC=CC2=CC=1)NS(C)(=O)=O)C1=CC=CC=C1 WGAXKIBBLQOPDQ-WXODNCMKSA-N 0.000 description 1
- WGAXKIBBLQOPDQ-OBBMFGNWSA-N 4-amino-n-[(e,2s,3r,6s)-3-benzyl-2-hydroxy-6-(methanesulfonamido)-7-naphthalen-2-ylsulfinylhept-4-enyl]-n-(2-methylpropyl)benzenesulfonamide Chemical compound C([C@@H]([C@H](O)CN(CC(C)C)S(=O)(=O)C=1C=CC(N)=CC=1)\C=C\[C@@H](CS(=O)C=1C=C2C=CC=CC2=CC=1)NS(C)(=O)=O)C1=CC=CC=C1 WGAXKIBBLQOPDQ-OBBMFGNWSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 102100039164 Acetyl-CoA carboxylase 1 Human genes 0.000 description 1
- 241000186361 Actinobacteria <class> Species 0.000 description 1
- 101100496009 Arabidopsis thaliana CIPK11 gene Proteins 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 101000836292 Klebsiella pneumoniae Type II restriction enzyme KpnI Proteins 0.000 description 1
- 241000222722 Leishmania <genus> Species 0.000 description 1
- LTYOQGRJFJAKNA-KKIMTKSISA-N Malonyl CoA Natural products S(C(=O)CC(=O)O)CCNC(=O)CCNC(=O)[C@@H](O)C(CO[P@](=O)(O[P@](=O)(OC[C@H]1[C@@H](OP(=O)(O)O)[C@@H](O)[C@@H](n2c3ncnc(N)c3nc2)O1)O)O)(C)C LTYOQGRJFJAKNA-KKIMTKSISA-N 0.000 description 1
- 108010085747 Methylmalonyl-CoA Decarboxylase Proteins 0.000 description 1
- 102100030979 Methylmalonyl-CoA mutase, mitochondrial Human genes 0.000 description 1
- 206010029155 Nephropathy toxic Diseases 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 240000000220 Panda oleosa Species 0.000 description 1
- 235000016496 Panda oleosa Nutrition 0.000 description 1
- 101100538974 Saccharomyces cerevisiae TY1B gene Proteins 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229940098178 ambisome Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000002141 anti-parasite Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 108010045673 endodeoxyribonuclease XBAI Proteins 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 239000003120 macrolide antibiotic agent Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- LTYOQGRJFJAKNA-DVVLENMVSA-N malonyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CC(O)=O)O[C@H]1N1C2=NC=NC(N)=C2N=C1 LTYOQGRJFJAKNA-DVVLENMVSA-N 0.000 description 1
- LTYOQGRJFJAKNA-VFLPNFFSSA-N malonyl-coa Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCSC(=O)CC(O)=O)O[C@H]1N1C2=NC=NC(N)=C2N=C1 LTYOQGRJFJAKNA-VFLPNFFSSA-N 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- -1 methylmalonyl Chemical group 0.000 description 1
- 230000007269 microbial metabolism Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000219 mutagenic Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 230000007694 nephrotoxicity Effects 0.000 description 1
- 231100000417 nephrotoxicity Toxicity 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 238000000643 oven drying Methods 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- QAQREVBBADEHPA-IEXPHMLFSA-N propionyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CC)O[C@H]1N1C2=NC=NC(N)=C2N=C1 QAQREVBBADEHPA-IEXPHMLFSA-N 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- VNOYUJKHFWYWIR-ITIYDSSPSA-N succinyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCC(O)=O)O[C@H]1N1C2=NC=NC(N)=C2N=C1 VNOYUJKHFWYWIR-ITIYDSSPSA-N 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/90—Isomerases (5.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/93—Ligases (6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
- C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
- C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y501/00—Racemaces and epimerases (5.1)
- C12Y501/99—Racemaces and epimerases (5.1) acting on other compounds (5.1.99)
- C12Y501/99001—Methylmalonyl-CoA epimerase (5.1.99.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y504/00—Intramolecular transferases (5.4)
- C12Y504/99—Intramolecular transferases (5.4) transferring other groups (5.4.99)
- C12Y504/99002—Methylmalonyl-CoA mutase (5.4.99.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y604/00—Ligases forming carbon-carbon bonds (6.4)
- C12Y604/01—Ligases forming carbon-carbon bonds (6.4.1)
- C12Y604/01002—Acetyl-CoA carboxylase (6.4.1.2)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
The invention discloses a recombinant Streptomyces tuberculatus for producing amphotericin B and application thereof, wherein the recombinant Streptomyces tuberculatus is obtained by knocking out competitive branches of amphotericin B in Streptomyces tuberculatus ZJB2016050(Streptomyces nodosus ZJB2016050) and then introducing functional gene tandem sequences shown in SEQ ID No.1, SEQ ID No.2, SEQ ID No.3, SEQ ID No.4 and SEQ ID No. 5; by introducing the functional gene, the supply of the amphotericin B skeleton synthetic precursor is comprehensively improved, the utilization rate of the strain on nutrient substances is improved, and the flow direction of the nutrient substances of a target product is changed. The yield of the AmB is improved by about 20% by knocking out a competition branch, the by-product amphotericin A is reduced by 40%, three precursors of acetyl coenzyme A, malonyl coenzyme A and methylmalonyl coenzyme A are improved by overexpression cascade functional gene verification, the yield of the amphotericin B is greatly improved, and finally the amphotericin B is fermented in a 5L fermentation tank, so that the yield of the amphotericin B can reach 16 g/L.
Description
(I) technical field
The invention relates to recombinant streptomyces tuberculatus for producing amphotericin B and application thereof.
(II) background of the invention
Amphotericin B (AmB) is a polyene broad-spectrum antifungal antibiotic produced by Streptomyces nodosus (nodosus), and its strain was collected and isolated from soil samples of delta of orinoco family of venezuelan in 1955. It was the first drug to be marketed in 1966 for deep fungal infections, which has been used for nearly half a century. AmB molecular formula C47H73NO17AmB belongs to the group of polyene macrolide antibiotics, has a broad spectrum of fungal resistance, particularly against life-threatening systemic fungal infections such as candida albicans, aspergillus, etc., and also has potent antiviral and antiparasitic properties such as raney virus, leishmania, etc., and currently marketed amphotericin B drugs include injections, tablets, etc. AmB is yellow or orange yellow powder, is tasteless and hygroscopic, and is easy to destroy and lose efficacy under sunlight. Can dissolve DMSO, and is substantially insoluble in water, anhydrous ethanol, chloroform or diethyl ether, and has a pH of less than 1mg/L (pH 6-7). The antifungal mechanism of AmB is: AmB can combine with ergosterol on fungal cell membrane to form micropores on the membrane, so that the permeability of the membrane is changed, and finally, the unregulated loss of important cell contents such as K ions, nucleotides, amino acids and the like is caused to cause cell death. However, AmB also interacts to a lesser extent with cholesterol on mammalian cell membranes, causing certain side effects, particularly nephrotoxicity. Although it has certain side effects, AmB is still the most important antibiotic currently used for the treatment of deep systemic fungal infections in humans. Research into new forms of AmB administration, such as Abelcet, Ambisome liposomal drugs, in the 90s of the 20 th century, has been intensified to increase the efficiency of drug access to the region of action in order to reduce toxicity. The fermentation direction and the research progress of the traditional mutagenesis are also provided, for example, Zhang Bo in 2017 and the like are used for mutagenizing wild streptomyces tubercle, the yield of amphotericin B is improved to 5.02g/L, the fermentation of mutagenic strains is optimized, and the industrialization of the amphotericin B with high yield is finally realized.
There are many ways of modifying microbial metabolism, and common methods include overexpression of functional genes, knockout of competitive branches, heterologous expression of synthetic gene clusters, and the like. The over-expression of functional genes is one of the main means in strain metabolic modification and has quick effect. The main genetic means of Streptomyces nodosus is conjugative transfer, and reference data show that the conjugation rate of the conjugative transfer of the Streptomyces nodosus is lower than that of the streptomyces model, wherein the success rate of integrative or temperature-sensitive plasmids such as pSET152, PKC1139 and the like is lower in operation and success rate. pJTU1278 as an expression plasmid is the only plasmid that is successfully transferred into the laboratory at present.
The amphotericin B backbone is composed mainly of 18 synthetic precursors and one starter unit, consisting of the polyketide synthase module amphA in combination with an acetyl-coa, followed by a stepwise build-up of 15 malonyl-coa and 3 methylmalonyl-coa. Where acetyl-CoA is derived primarily from the glycolytic pathway of glucose, malonyl-CoA is synthesized primarily from acetyl-CoA under the action of acetyl-CoA carboxylase, methylmalonyl-CoA is synthesized from two pathways, one from succinyl-CoA under the action of methylmalonyl isomerase and mutase and one from propionyl-CoA under the action of propionyl-CoA carboxylase. acetyl-CoA is a core substance of biological metabolism, and the metabolic branches in organisms are complex and are one of the main precursors of secondary metabolites.
Streptomyces is a natural treasure house called secondary metabolite of actinomycetes, and streptomyces often has a plurality of secondary metabolite synthesis gene clusters, some of which may be silent gene clusters, and can realize expression under specific stress. Another part may be in a different expression state, and there is also a competitive effect. Within S.nodularis there are 5 PKS type synthetic gene clusters, of which amphotericin B belongs to PKS type I. According to the prediction result of the anti SMASH and the data of the KEGG, the secondary metabolite of PKS5 is found to have a competitive effect on the synthesis of amphotericin B.
Disclosure of the invention
The invention aims to provide recombinant streptomyces tuberculatus for producing amphotericin B (AmB) and application thereof, and the recombinant streptomyces tuberculatus can improve the amount of precursor substances in the streptomyces tuberculatus or improve the utilization rate of the precursor substances and effectively improve the yield of the AmB by expressing functional genes in the streptomyces tuberculatus.
The technical scheme adopted by the invention is as follows:
a recombinant Streptomyces tuberculatus for producing amphotericin B is obtained by knocking out PKS5 gene cluster shown in SEQ ID NO.6 from Streptomyces nodosus ZJB2016050 (i.e. CCTCC NO: M2017426) gene, and introducing acetyl coenzyme A carboxylase 1 gene shown in SEQ ID NO.1, acetyl coenzyme A carboxylase 2 gene shown in SEQ ID NO.2, polyketide synthase PKSamphA gene shown in SEQ ID NO.3, methylmalonyl coenzyme A mutase gene shown in SEQ ID NO.4 and tandem gene of methylmalonyl coenzyme A isomerase gene shown in SEQ ID NO. 5.
Preferably, the recombinant Streptomyces sarcomere is Streptomyces sarcomere ZJB 50-RAAAmm (Streptomyces nodosus ZJB2016050-RAAAmm), and is deposited in China center for type culture Collection with the address: wuhan university, Wuhan, China, zip code 430072, preservation number: CCTCC NO: m2019341, date of deposit 2019, 09/05 month.
The method for introducing the recombinant vector into the host bacteria is an inter-species conjugation transfer method, and the method can be as follows:
knocking out:
1) homologous arm fragments (each 3000bp) on two sides of the gene are knocked out through PCR amplification, and are inserted into a polyclonal locus of pJTU1278 vector plasmid to obtain a recovered vector pJTU 1278-RE;
2) the cloned kana resistance gene is inserted between two homologous arms of pJTU1278-Re to be used as a knockout screening marker, and a recovery vector pJTU1278-DE is obtained.
And (3) overexpression step:
1) inserting acetyl coenzyme A carboxylase 1 gene (acc1) obtained by PCR cloning and a promoter into a polyclonal locus of pJTU1278 vector plasmid to obtain a recombinant vector pJTU1278-acc 1;
2) transforming the recombinant vector obtained in the step 1) into escherichia coli JM109, sequencing the obtained transformant, and introducing the vector which is confirmed to be error-free into donor escherichia coli ET12567/pUZ 8002;
3) inserting acetyl coenzyme A carboxylase 2 gene (acc2), polyketide synthase PKSamphA, methylmalonyl coenzyme A mutase (mcm) and methylmalonyl coenzyme A isomerase (mme) into the constructed plasmid in the order of steps 1) and 2). Finally, the plasmid pJTU1278-acc1-acc2-amphA-mcm-mme is obtained.
4) Transforming the donor bacterium escherichia coli ET12567/pUZ8002/pJTU1278-acc1-acc2-amphA-mcm-mme containing the recombinant vector obtained in the step 3) into a recipient bacterium (namely CCTCC NO: m2017426), obtaining the genetically engineered bacteria with high-yield amphotericin B.
The invention also relates to application of the recombinant streptomyces tuberculatus in preparation of amphotericin B by microbial fermentation.
Specifically, the application is as follows: inoculating the recombinant streptomyces tuberculatus for producing amphotericin B to a fermentation culture medium, carrying out fermentation culture at 25-30 ℃ and 200-500 rpm to obtain fermentation liquor containing amphotericin B, and separating and purifying the fermentation liquor to obtain amphotericin B; the final concentration of the fermentation medium is as follows: 60-80 g/L of glucose, 5-10 g/L of beef extract, 5-10 g/L of soybean protein powder, 8-12 g/L of cotton seed powder and CaCO 3 5~10g/L,KH2PO40.1-0.4 g/L, water as solvent, and pH 7.0.
The fermentation culture is usually carried out in a fermentation tank, the pressure of the fermentation tank is 0.05MPa, and the aeration ratio is 0.08-1.5 vvm.
Preferably, before fermentation culture, the streptomyces tuberculatus producing amphotericin B is subjected to seed culture, and then a seed solution is inoculated to a fermentation medium in an inoculum size of 2-10% by volume concentration, wherein the seed culture is as follows: inoculating recombinant streptomyces tuberculatus producing amphotericin B to a GYM plate, culturing at 28 ℃ for 7 days, taking gray and black spores, eluting surface spores into sterile water by using a cotton stick, filtering washed spore suspension by using an injector containing cotton, centrifuging at 12000rpm for 5min, removing supernatant, adding sterile water into a precipitate for re-suspension, centrifuging at 12000rpm for 5min, re-eluting once, re-suspending with sterile water to serve as spore suspension, inoculating the spore suspension into a seed culture medium, and culturing at 28 ℃ and 220rpm for 46h to obtain seed liquid; the final concentration of the GYM plate is as follows: 4g/L of glucose, 4g/L of yeast powder, 10g/L of malt extract, 2g/L of calcium carbonate, 18g/L of agar and water as a solvent, wherein the pH value is 7.2; the final concentration of the seed liquid culture medium is as follows: 10-20 g/L of peptone, 5-10 g/L of NaCl, 10-15 g/L of glucose, 5-10 g/L of yeast powder and CaCO30.5-1 g/L, water as solvent, and pH 7.0.
Compared with the prior art, the invention has the following beneficial effects:
1. over-expressing precursor supply related functional protein on the basis of strain knockout, increasing precursor supply amount and improving the yield of amphotericin B by 20 percent.
2. The utilization rate of the nutrient components of the culture medium in the fermentation process of the strain is improved, and the fermentation period is shortened, so that the risk of bacterial contamination is reduced.
3. Kanamycin has the advantages of low price, wide antimicrobial spectrum and strong bactericidal action, is suitable for industrial use, has strong improvement effect on the total income rate of enterprises, and can reduce the cost by about 2000 yuan per tank by taking a laboratory 5L tank as calculation.
(IV) description of the drawings
FIG. 1 is a map of a replacement restored plasmid constructed in example 1 of the present invention;
FIG. 2 is a map of kan-resistant replacement plasmids constructed in example 1 of the present invention;
FIG. 3 is a diagram showing the construction of functional gene tandem in example 4;
FIG. 4 shows the fermentation results of the recombinant Streptomyces nodosus 5L fermenter in example 7;
FIG. 5 is a standard curve for AmB High Performance Liquid Chromatography (HPLC) detection in example 9.
(V) detailed description of the preferred embodiments
The invention will be further described with reference to specific examples, but the scope of the invention is not limited thereto:
example 1: knock-out vector construction
1. Homology arm 1 insertion
Taking the whole genome of streptomyces nodosus ATCC14899 as a template, designing primers TYB1-F and TYB1-R, TYB1-F as a forward primer aiming at the homologous arm 1, TYB1-R as a reverse primer aiming at the homologous arm 1 gene, cloning and amplifying the homologous arm 1 gene from the template, wherein the size of the fragment is about 3000bp, the fragment accords with a target fragment, sequencing analysis shows that the amplified sequence is the same as the target gene sequence, the fragment is cut by endonuclease XbaI and BamHI, the clean-up fragment is reserved, a vector pJTU1278 is also recovered by the same XbaI and BamHI endonuclease digestion glue, the recovered gene fragment is connected with a cut pJTU1278 vector, and the recombined plasmid vector is named as pJTU1278-TYB 1.
Wherein the cloning of the PCR system: add Streptomyces nodosus ATCC14899 whole genome template 1 u L, add 2 x Phanta Max Buffer 25 u L, dNTP (2.5mM)5 u L, TYB1 positive and negative primer each 1 u L, Phanta Max DNA polymerase 1 u L, make up deionized water to 50 u L.
Wherein the cloning PCR procedure: denaturation at 98 ℃ for 10s, annealing at 55-60 ℃ for 15s, and extension at 72 ℃ for 3min for 30 cycles. Finally, extension is carried out for 10min at 72 ℃.
Wherein the connection process is as follows: add 1. mu.L of T4 DNA ligase buffer to the sterilized PCR tube, add 4. mu.L of the recovered DNA fragment and 1. mu.L of the vector DNA, add 1. mu.L of T4 DNA ligase, add ddH2Mu.l of O3, and reacting at 16 ℃ for 20 hours. The ligation products were transformed into JM109, which was competent for E.coli, and transformants were selected for validation by ampicillin resistance screening.
The primers used were as follows:
2. homology arm 2 insertion
Taking the whole genome of Streptomyces nodosus ATCC14899 as a template, designing primers TYB2-F and TYB2-R, wherein TYB2-F is a forward primer aiming at the homologous arm 2, TYB2-R is a reverse primer aiming at the homologous arm 2 gene, cloning and amplifying the homologous arm 2 gene from the template, wherein the size of the fragment is about 3000bp, the fragment is consistent with a target fragment, sequencing analysis shows that the amplified sequence is the same as the target gene sequence, the fragment is cut by endonuclease HindIII and KpnI, then clear-up fragment is reserved, a vector pJTU1278-TYB1 is recovered by the same endonuclease digestion glue, and the recovered gene fragment is connected with a cut pJTU1278-TYB1 vector to obtain a recombinant plasmid vector named as pJTU1278-TYB1-TYB2, as shown in figure 1.
Wherein the cloning of the PCR system: add Streptomyces nodosus ATCC14899 whole genome template 1 u L, add 2 x Phanta Max Buffer 25 u L, dNTP (2.5mM)5 u L, TYB2 positive and negative primer each 1 u L, Phanta Max DNA polymerase 1 u L, make up deionized water to 50 u L.
Wherein the cloning PCR procedure: denaturation at 98 ℃ for 10s, annealing at 55-60 ℃ for 15s, and extension at 72 ℃ for 3min for 30 cycles. Finally, extension is carried out for 10min at 72 ℃.
Wherein the connection process is as follows: add 1. mu.L of T4 DNA ligase buffer to the sterilized PCR tube, add 4. mu.L of the recovered DNA fragment and 1. mu.L of the vector DNA, add 1. mu.L of T4 DNA ligase, add ddH2Mu.l of O3, and reacting at 16 ℃ for 20 hours. The ligation products were transformed into JM109, which was competent for E.coli, and transformants were selected for validation by ampicillin resistance screening.
The primers used were as follows:
3. resistance selection tag insertion
pET28b is used as a template to design primers kan-F and kan-R, wherein kan-F is a forward primer aiming at the kala resistance gene, kan-R is a reverse primer aiming at the kala resistance gene, the kala resistance gene is cloned and amplified from the template, the size of the fragment is about 900bp, the fragment accords with the target fragment, sequencing analysis shows that the sequence obtained by amplification is the same as the target gene sequence, the fragment is cut by endonuclease HindIII and BamHI, clean-up is reserved, a vector pJTU1278-TYB1-TYB2 is also recovered by the same HindIII and BamHI endonuclease digestion glue, the recovered gene fragment is connected with the cut pJTU1278-TYB1-TYB2 vector, and a recombinant plasmid vector is named as pJTU1278-TYB1-kan-TYB2, as shown in figure 2.
Wherein the cloning of the PCR system: mu.L of Streptomyces nodularis ATCC14899 whole genome template was added, 25. mu.L of 2 XPhanta Max Buffer, 5. mu.L of dNTP (2.5mM), 1. mu.L of each of the kanamycin-resistant gene forward and reverse primers, 1. mu.L of Phanta Max DNA polymerase, and deionized water was added to make up to 50. mu.L.
Wherein the cloning PCR procedure: denaturation at 98 ℃ for 10s, annealing at 55-60 ℃ for 15s, and extension at 72 ℃ for 1min for 30 cycles. Finally, extension is carried out for 10min at 72 ℃.
Wherein the connection process is as follows: add 1. mu.L of T4 DNA ligase buffer to the sterilized PCR tube, add 4. mu.L of the recovered DNA fragment and 1. mu.L of the vector DNA, add 1. mu.L of T4 DNA ligase, add ddH2Mu.l of O3, and reacting at 16 ℃ for 20 hours. The ligation products were transformed into JM109, which was competent for E.coli, and transformants were selected for validation by ampicillin resistance screening.
The primers used were as follows:
example 2: resistant genomic replacement
Recombinant vector pJTU1278-TYB1-kan-TYB2 conjugation transfer transformation recipient bacterium Streptomyces tubercle A) preparation of E.coil ET12567/puz8002 Donor bacterium containing recombinant vector pJTU1278-TYB1-kan-TYB 2:
the constructed recombinant vector pJTU1278-TYB1-kan-TYB2 was introduced into E.coil ET12567/puz8002 Escherichia coli competence, using ampicillin (Amp)+50. mu.g/mL), chloramphenicol (Cm)+50. mu.g/mL), kanamycin (Kan)+50. mu.g/mL), positive transformants were picked and verified by colony PCR with primers upstream and downstream of M13, which demonstrated successful transformation of the recombinant vector pJTU1278-TYB1-kan-TYB2 into E.coil ET12567/puz 8002. The specific operation is as follows:
coli ET12567/puz8002 escherichia coli competent preparation method as follows:
taking E.coil ET12567/puz8002 Escherichia coli liquid from a glycerol freezing tube of the strain, streaking the liquid on an LB plate in a partition way, and culturing at 37 ℃ until a single colony grows out. Single colonies on the plate were picked and transferred to 2-5 mL LB medium at 37 ℃ and cultured overnight at 200 rpm. 200 mu L of overnight-cultured bacterial liquid is added into 20mL LB culture medium at 37 ℃, and cultured at 200rpm until OD600 is 0.4-0.7. The cultured bacterial liquid is transferred to a precooled 50mL centrifuge tube and is kept stand for 10min on ice. Centrifuge at 4 deg.C, 2500 Xg, 5 min. The supernatant was discarded, and 4mL of 0.1mol/L CaCl was added2And standing for 10min after resuspension on ice. Centrifuge at 4 deg.C, 2500 Xg, 5 min. The supernatant was discarded, and 2mL of 0.1mol/L CaCl was added2(15% final glycerol) and resuspend the pellet and allow to stand on ice for 30min to obtain E.coil ET12567/puz8002 E.coli competent cells. Subpackaging with 100 μ L/tube, and preserving at-80 deg.C.
Preparation of E.coil ET12567/puz8002 Donor bacteria containing the recombinant vector pJTU1278-TYB1-kan-TYB 2:
1 piece of the E.coil ET12567/puz8002 Escherichia coli competent cells was taken, ice-cooled for 5min, 5. mu.L of pJTU1278-TYB1-kan-TYB2 vector plasmid with a concentration of 200 ng/. mu.L was added, ice-cooled for 30min, water bath at 42 ℃ was performed, heat shock was performed for 90s, ice-cooled for 1min was returned, 600. mu.L of LB liquid medium was added, and culture was performed at 37 ℃ and 200rpm for 1 h. mu.L of the solution was pipetted and uniformly applied to Kan + (final concentration 50. mu.g/mL), Cm + (final concentration 50. mu.g/mL), Amp + (final concentration 50. mu.g/mL) resistant LB solid plate, and cultured in an incubator at 37 ℃ for 14 hours. Until a single E.coil ET12567/puz8002 colony containing the recombinant vector pJTU1278-TYB1-kan-TYB2 grows.
M13 validation PCR system: picking single colony, adding 20 microliter of sterile water, carrying out boiling water bath for 5-10 min, and centrifuging at 12000rpm for 1 min. mu.L of the supernatant was used as a template, and 10. mu.L of pfu Buffer, 0.1. mu.L of dNTP (2.5mM), 0.1. mu.L of each of M13 forward and reverse primers, 0.1. mu.L of pfu DNA polymerase, and 10. mu.L of deionized water were added thereto.
M13 validation PCR program: denaturation at 98 ℃ for 10s, annealing at 55-60 ℃ for 15s, and extension at 72 ℃ for 8min for 30 cycles. Finally, extension is carried out for 10min at 72 ℃.
The M13 primers were as follows:
M13(-21)F | TGTAAAACGACGGCCAGT |
M13 R | CAGGAAACAGCTATGAC |
the E.coli ET12567/puz8002 into which the pJTU1278-TYB1-Kan-TYB2 plasmid has been introduced is streaked to separate a single colony, cultured at 37 ℃, picked up in a tube containing 5mL of LB medium, and simultaneously Kan is added+(final concentration 50. mu.g/mL), Cm+(final concentration 50. mu.g/mL), Amp+(final concentration 50. mu.g/mL) antibiotic, incubated at 37 ℃ for 14 h. Transfer 500. mu.L into 50mL LB flask while adding Kan+(final concentration 50. mu.g/mL), Cm+(final concentration 50. mu.g/mL), Amp+(final concentration 50. mu.g/mL) resistance, incubation to OD at 37 ℃600Is 0.35. The donor was centrifuged through a 50mL centrifuge tube at 4000rpm for 5min, washed twice with 50mL LB medium, resuspended in 5mL LB medium, and stored at 4 ℃ until use.
Wherein the LB culture medium is prepared by the following method: 10g of peptone, 5g of yeast powder, 5g of sodium chloride and tap water, wherein the volume is constant to 1L, the pH is natural, and the sterilization is carried out at 121 ℃ for 20 min.
B) Preparation of recipient bacterium Streptomyces nodosus
Streptomyces nodosus ZJB2016050(CCTCC M2017426) of laboratory strains is inoculated on a GyM plate or slant culture, grown at 28 ℃ for 10d to obtain gray black spores, the surface spores are eluted into 10mL of 2 XYT medium by using a cotton stick, the washed spore suspension is filtered by a syringe containing cotton, 12000rpm of the filtered spores is obtained, the supernatant is removed after centrifugation for 5min, 10mL of 2 XYT medium is added for resuspension, 12000rpm is obtained for 5min for re-elution, and finally 500 μ L of 2 XYT medium is used for resuspension. And thermally shocking the resuspended spores at 50 ℃ for 15-20 min, and keeping the spores at normal temperature for later use.
Wherein the 2 XYT medium is prepared by the following method: 16g of peptone, 10g of yeast powder, 5g of sodium chloride and tap water, wherein the volume is fixed to 1L, the pH is natural, and the sterilization is carried out at 121 ℃ for 20 min.
The preparation method of the GYM solid culture medium comprises the following steps: 4g of glucose, 4g of yeast powder, 10g of malt extract, 2g of calcium carbonate, 18g of agar and tap water with the constant volume of 1L, the pH value of 7.2 and the sterilization at 121 ℃ for 20 min.
C) The process of joining donor and recipient bacteria:
after mixing 500. mu.L of the heat-shocked spore suspension of step B) with 500. mu.L of the donor E.coli suspension of step A), resuspension was performed by centrifugation at 6000rpm for 2min, 800. mu.L of the supernatant was removed, and the pellet was resuspended and spread on a MS solid medium plate containing 10mM magnesium chloride in the remaining supernatant. After culturing at 28 ℃ for 20h, 1mL of aqueous solution containing 0.5mg of napadiramic acid and 0.5mg of thiostrepton antibiotic was applied, and the culture was continued at 28 ℃ for 10 days until transformants appeared.
The transformant was continuously purified 3 times on a solid plate containing naphtholic acid at a final concentration of 50. mu.g/mL and kanamycin-resistant at a final concentration of 50. mu.g/mL until a single colony was obtained, and after PCR verification of the colony of the transformant using 16S RNA upstream and downstream primers (16S-8 and 16S-1541) and M13 upstream and downstream primers (M13(-21) F, M13R), sequencing comparative analysis confirmed that the plasmid (pJTU1278-TYB1-kan-TYB2) had been introduced into the recipient bacterium Streptomyces nodosus ZJB 50, and finally the genetically engineered bacterium that produces AmB, i.e., Streptomyces nodosus pJTU1278-TYB1-kan-TYB2, was obtained. Adding Kan through several rounds of resistance culture+(final concentration 50. mu.g/mL) to obtain the final successfully replaced strain Streptomyces nodosus ZJB2016050-De 5.
Wherein the MS solid culture medium is prepared by the following method: 20g of soybean meal, 20g of mannitol, 20g of agar and tap water, wherein the volume is constant to 1L, the pH value is adjusted to 7.2 by sodium hydroxide, and the mixture is sterilized at 121 ℃ for 20 min. Sterile magnesium chloride was added to a final concentration of 10mM before use.
Wherein M13 verifies that the PCR operation is as described in step A).
Wherein the 16sRNA verifies the PCR system: single colonies were picked, 20. mu.L of sterile water was added, and centrifuged at 12000rpm for 1min in a boiling water bath for 30 min. mu.L of the supernatant was used as a template, and 2X Phanta Max Buffer (5. mu.L), dNTP (2.5mM) 0.1. mu.L, 16S forward and reverse primers (0.1. mu.L each), Phanta Max DNA polymerase (0.1. mu.L) and deionized water were added to make up to 10. mu.L.
Among them 16S RNA validation PCR program: denaturation at 98 ℃ for 10s, annealing at 55-60 ℃ for 15s, and extension at 72 ℃ for 1min for 30s for 30 cycles. Finally, extension is carried out for 10min at 72 ℃.
The primers used were as follows:
16S-8 | AGAGTTTGATCCTGGCTCAG |
16S-1541 | AAGGAGGTGATCCAGCCGCA |
M13(-21)F | TGTAAAACGACGGCCAGT |
example 3: knock-out resistance tag reconstitution
Recombinant vector pJTU1278-TYB1-TYB2 conjugately transfers recipient bacterium Streptomyces nodosus ZJB2016050-De5
A) Preparation of E.coil ET12567/puz8002 Donor bacteria containing the recombinant vector pJTU1278-TYB1-TYB 2:
the constructed recombinant vector pJTU1278-TYB1-TYB2 was introduced into E.coil ET12567/puz8002 Escherichia coli competence using ampicillin (Amp)+50. mu.g/mL), chloramphenicol (Cm)+50. mu.g/mL), kanamycin (Kan)+50. mu.g/mL), positive transformants were picked and verified by colony PCR with primers upstream and downstream of M13, which demonstrated successful transformation of the recombinant vector pJTU1278-TYB1-TYB2 into E.coil ET12567/puz 8002. The specific operation is as follows:
coli ET12567/puz8002 escherichia coli competent preparation method as follows:
taking E.coil ET12567/puz8002 Escherichia coli liquid from a glycerol freezing tube of the strain, streaking the liquid on an LB plate in a partition way, and culturing at 37 ℃ until a single colony grows out. Single colonies on the plate were picked and transferred to 2-5 mL LB medium at 37 ℃ and cultured overnight at 200 rpm. 200 mu L of overnight-cultured bacterial liquid is added into 20mL LB culture medium at 37 ℃, and cultured at 200rpm until OD600 is 0.4-0.7. The cultured bacterial liquid is transferred to a precooled 50mL centrifuge tube and is kept stand for 10min on ice. Centrifuge at 4 deg.C, 2500 Xg, 5 min. The supernatant was discarded, and 4mL of 0.1mol/L CaCl was added2And standing for 10min after resuspension on ice. Centrifuge at 4 deg.C, 2500 Xg, 5 min. The supernatant was discarded, and 2mL of 0.1mol/L CaCl was added2(15% final glycerol) and resuspend the pellet and allow to stand on ice for 30min to obtain E.coil ET12567/puz8002 E.coli competent cells. Subpackaging 100 mu L/tube stored at-80 ℃.
Preparation of E.coil ET12567/puz8002 Donor bacteria containing the recombinant vector pJTU1278-TYB1-TYB 2:
1 piece of the E.coil ET12567/puz8002 Escherichia coli competent cells are taken, ice-cooled for 5min, 5 uL of pJTU1278-TYB1-TYB2 vector plasmid with the concentration of 200 ng/uL is added, ice-cooled for 30min, and then the mixture is put into a water bath at 42 ℃ and heat shock for 90s and then put back into the ice bath for 1min, 600 uL of LB liquid culture medium is added, and the mixture is cultured for 1h at 37 ℃ and 200 rpm. mu.L of the solution was pipetted and uniformly applied to Kan + (final concentration 50. mu.g/mL), Cm + (final concentration 50. mu.g/mL), Amp + (final concentration 50. mu.g/mL) resistant LB solid plate, and cultured in an incubator at 37 ℃ for 14 hours. Until a single E.coil ET12567/puz8002 colony containing the recombinant vector pJTU1278-TYB1-TYB2 grows.
M13 validation PCR system: picking single colony, adding 20 microliter of sterile water, carrying out boiling water bath for 5-10 min, and centrifuging at 12000rpm for 1 min. mu.L of the supernatant was used as a template, and 10. mu.L of pfu Buffer, 0.1. mu.L of dNTP (2.5mM), 0.1. mu.L of each of M13 forward and reverse primers, 0.1. mu.L of pfu DNA polymerase, and 10. mu.L of deionized water were added thereto.
M13 validation PCR program: denaturation at 98 ℃ for 10s, annealing at 55-60 ℃ for 15s, and extension at 72 ℃ for 8min for 30 cycles. Finally, extension is carried out for 10min at 72 ℃.
The M13 primers were as follows:
M13(-21)F | TGTAAAACGACGGCCAGT |
M13 R | CAGGAAACAGCTATGAC |
the E.coli ET12567/puz8002 into which the pJTU1278-TYB1-TYB2 plasmid has been introduced is streaked to separate a single colony, cultured at 37 ℃, picked in a tube containing 5mL of LB medium, andwith simultaneous addition of Kan+(final concentration 50. mu.g/mL), Cm+(final concentration 50. mu.g/mL), Amp+(final concentration 50. mu.g/mL) antibiotic, incubated at 37 ℃ for 14 h. Transfer 500. mu.L into 50mL LB flask while adding Kan+(final concentration 50. mu.g/mL), Cm+(final concentration 50. mu.g/mL), Amp+(final concentration 50. mu.g/mL) resistance, incubation to OD at 37 ℃600Is 0.35. The donor was centrifuged through a 50mL centrifuge tube at 4000rpm for 5min, washed twice with 50mL LB medium, resuspended in 5mL LB medium, and stored at 4 ℃ until use.
Wherein the LB culture medium is prepared by the following method: 10g of peptone, 5g of yeast powder, 5g of sodium chloride and tap water, wherein the volume is constant to 1L, the pH is natural, and the sterilization is carried out at 121 ℃ for 20 min.
B) Preparation of recipient bacterium Streptomyces nodosus
The laboratory strains of Streptomyces nodosus ZJB2016050-De5 were inoculated on GYM plate or slant culture, grown at 28 ℃ for 10d to obtain gray black spores, surface spores were eluted into 10mL of 2 XYT medium using cotton stick, the washed spore suspension was filtered with a syringe containing cotton, the filtered spores were 12000rpm, centrifuged for 5min, the supernatant was removed, 10mL of 2 XYT medium was added for resuspension, centrifuged at 12000rpm for 5min and re-eluted, and finally resuspended in 500. mu.L of 2 XYT medium. And thermally shocking the resuspended spores at 50 ℃ for 15-20 min, and keeping the spores at normal temperature for later use.
Wherein the 2 XYT medium is prepared by the following method: 16g of peptone, 10g of yeast powder, 5g of sodium chloride and tap water, wherein the volume is fixed to 1L, the pH is natural, and the sterilization is carried out at 121 ℃ for 20 min.
The preparation method of the GYM solid culture medium comprises the following steps: 4g of glucose, 4g of yeast powder, 10g of malt extract, 2g of calcium carbonate, 18g of agar and tap water with the constant volume of 1L, the pH value of 7.2 and the sterilization at 121 ℃ for 20 min.
C) The process of joining donor and recipient bacteria:
after mixing 500. mu.L of the heat-shocked spore suspension of step B) with 500. mu.L of the donor E.coli suspension of step A), resuspension was performed by centrifugation at 6000rpm for 2min, 800. mu.L of the supernatant was removed, and the pellet was resuspended and spread on a MS solid medium plate containing 10mM magnesium chloride in the remaining supernatant. After culturing at 28 ℃ for 20h, 1mL of aqueous solution containing 0.5mg of napadiramic acid and 0.5mg of thiostrepton antibiotic was applied, and the culture was continued at 28 ℃ for 10 days until transformants appeared.
The transformant was continuously purified 3 times on a solid plate containing naphtholic acid at a final concentration of 50. mu.g/mL and kanamycin-resistant at a final concentration of 50. mu.g/mL until a single colony was obtained, and after PCR verification of the colony of the transformant using 16S RNA upstream and downstream primers (16S-8 and 16S-1541) and M13 upstream and downstream primers (M13(-21) F, M13R), sequencing comparative analysis confirmed that the plasmid (pJTU1278-TYB1-TYB2) had been introduced into the recipient bacterium Streptomyces nodosus ZJB2016050-De5, and finally the genetically engineered bacterium producing AmB, i.e., recombinant Streptomyces tubercle pJTU1278-TYB1-TYB2, was obtained. Through several rounds of resistance culture, adding Kan+(final concentration 50. mu.g/mL) to obtain the final successfully replaced strain Streptomyces nodosus ZJB2016050-Re 5.
Wherein the MS solid culture medium is prepared by the following method: 20g of soybean meal, 20g of mannitol, 20g of agar and tap water, wherein the volume is constant to 1L, the pH value is adjusted to 7.2 by sodium hydroxide, and the mixture is sterilized at 121 ℃ for 20 min. Sterile magnesium chloride was added to a final concentration of 10mM before use.
Wherein M13 verifies that the PCR operation is as described in step A).
Wherein the 16sRNA verifies the PCR system: single colonies were picked, 20. mu.L of sterile water was added, and centrifuged at 12000rpm for 1min in a boiling water bath for 30 min. mu.L of the supernatant was used as a template, and 2X Phanta Max Buffer (5. mu.L), dNTP (2.5mM) 0.1. mu.L, 16S forward and reverse primers (0.1. mu.L each), Phanta Max DNA polymerase (0.1. mu.L) and deionized water were added to make up to 10. mu.L.
Among them 16S RNA validation PCR program: denaturation at 98 ℃ for 10s, annealing at 55-60 ℃ for 15s, and extension at 72 ℃ for 1min for 30s for 30 cycles. Finally, extension is carried out for 10min at 72 ℃.
Example 4: construction of functional Gene tandem vector
Taking the whole genome of Streptomyces nodosus ATCC14899 as a template, designing primers mcm-F and mcm-R, cloning and amplifying an acetyl-CoA carboxylase 1 gene (acc1), a fragment size of about 1776bp, an acetyl-CoA carboxylase 2 gene (acc2), a fragment size of about 1941bp, a polyketide synthase PKSamphA, a fragment size of about 4239bp, a methylmalonyl-CoA mutase (mcm), a fragment size of about 1737bp, a methylmalonyl-CoA isomerase (mme) fragment size of about 441bp, which are consistent with a target fragment, and according to sequencing analysis, the amplified sequence is identical to the target gene sequence, the nucleotide sequence of the acetyl-CoA carboxylase 1(acc1) gene is shown as SEQ ID No.1, the nucleotide sequence of the acetyl-CoA carboxylase 2 gene (acc2) is shown as SEQ ID No.2, and the nucleotide sequence of the synthase PKhA gene is shown as Samph No.3, the nucleotide sequence of methylmalonyl-CoA mutase (mcm) gene is shown in SEQ ID No.4, and the nucleotide sequence of methylmalonyl-CoA isomerase gene (mme) is shown in SEQ ID No. 5. The fragment is cut by endonuclease BamHI and HindIII, clean-up is reserved, vector pJTU1278 is recovered by the same BamHI and HindIII endonuclease digestion gel, the recovered gene fragment is connected with the cut pJTU1278 vector to obtain a recombinant plasmid vector named as pJTU1278-acc1-acc2-amphA-mcm-mme, and the schematic diagram is shown in figure 3.
Wherein the cloning of the PCR system: add 1. mu.L of genomic template, 2 XPPhanta Max Buffer 25. mu.L of dNTP (2.5mM) 5. mu.L of the corresponding forward and reverse primers, 1. mu.L of each, Phanta Max DNA polymerase 1. mu.L, make up deionized water to 50. mu.L.
Wherein the cloning PCR procedure: denaturation at 98 ℃ for 10s, annealing at 55-60 ℃ for 15s, and extension at 72 ℃ for 2min for 30 cycles. Finally, extension is carried out for 10min at 72 ℃.
Wherein the connection process is as follows: adding 1. mu.L of T4 DNA ligase buffer to a sterilized PCR tube, adding 4. mu.L of the recovered DNA fragment and 1. mu.L of the vector DNA, adding 1. mu.L of T4 DNA ligase, and adding ddH2O3. mu.L, and reacted at 16 ℃ for 20 hours. The ligation products were transformed into JM109, which was competent for E.coli, and transformants were selected for validation by ampicillin resistance screening.
Example 5: functional gene expression
The constructed recombinant vector pJTU1278-acc1-acc2-amphA-mcm-mme is introduced into E.coil ET12567/puz8002 escherichia coli competence, using ampicillin (Amp)+50. mu.g/mL), chloramphenicol (Cm)+50. mu.g/mL), kanamycin (Kan)+50 mu g/mL), selecting positive transformant, verifying by colony PCR of upstream and downstream primers of M13, and proving that the recombinant vector pJTU1278-acc1-acc2-amphA-mcm-mme was successfully transformed into E.coil ET12567/puz 8002. The specific operation is as follows:
coli ET12567/puz8002 escherichia coli competent preparation method as follows:
taking E.coil ET12567/puz8002 Escherichia coli liquid from a glycerol freezing tube of the strain, streaking the liquid on an LB plate in a partition way, and culturing at 37 ℃ until a single colony grows out. Single colonies on the plate were picked and transferred to 2-5 mL LB medium at 37 ℃ and cultured overnight at 200 rpm. 200 mu L of overnight-cultured bacterial liquid is added into 20mL LB culture medium at 37 ℃, and cultured at 200rpm until OD600 is 0.4-0.7. The cultured bacterial liquid is transferred to a precooled 50mL centrifuge tube and is kept stand for 10min on ice. Centrifuge at 4 deg.C, 2500 Xg, 5 min. The supernatant was discarded, and 4mL of 0.1mol/L CaCl was added2And standing for 10min after resuspension on ice. Centrifuge at 4 deg.C, 2500 Xg, 5 min. The supernatant was discarded, and 2mL of 0.1mol/L CaCl was added2(15% final glycerol) and resuspend the pellet and allow to stand on ice for 30min to obtain E.coil ET12567/puz8002 E.coli competent cells. Subpackaging with 100 μ L/tube, and preserving at-80 deg.C.
E.coil ET12567/puz8002 donor bacteria containing recombinant vector pJTU1278-acc1-acc 2-amphA-mcm-mme:
1 piece of the E.coil ET12567/puz8002 Escherichia coli competent cells are taken, ice-cooled for 5min, 5 uL of pJTU1278-TYB1-TYB2 vector plasmid with the concentration of 200 ng/uL is added, ice-cooled for 30min, and then the mixture is put into a water bath at 42 ℃ and heat shock for 90s and then put back into the ice bath for 1min, 600 uL of LB liquid culture medium is added, and the mixture is cultured for 1h at 37 ℃ and 200 rpm. mu.L of the solution was pipetted and uniformly applied to Kan + (final concentration 50. mu.g/mL), Cm + (final concentration 50. mu.g/mL), Amp + (final concentration 50. mu.g/mL) resistant LB solid plate, and cultured in an incubator at 37 ℃ for 14 hours. Until a single E.coil ET12567/puz8002 colony containing the recombinant vector pJTU1278-acc1-acc2-amphA-mcm-mme grew.
M13 validation PCR system: picking single colony, adding 20 microliter of sterile water, carrying out boiling water bath for 5-10 min, and centrifuging at 12000rpm for 1 min. mu.L of the supernatant was used as a template, and 10. mu.L of pfu Buffer, 0.1. mu.L of dNTP (2.5mM), 0.1. mu.L of each of M13 forward and reverse primers, 0.1. mu.L of pfu DNA polymerase, and 10. mu.L of deionized water were added thereto.
M13 validation PCR program: denaturation at 98 ℃ for 10s, annealing at 55-60 ℃ for 15s, and extension at 72 ℃ for 8min for 30 cycles. Finally, extension is carried out for 10min at 72 ℃.
The M13 primers were as follows:
M13(-21)F | TGTAAAACGACGGCCAGT |
M13 R | CAGGAAACAGCTATGAC |
the E.coli ET12567/puz8002 into which the pJTU1278-acc1-acc2-amphA-mcm-mme plasmid has been introduced is streaked to separate a single colony, cultured at 37 ℃, picked into a test tube containing 5mL of LB medium, and simultaneously added with Kan+(final concentration 50. mu.g/mL), Cm+(final concentration 50. mu.g/mL), Amp+(final concentration 50. mu.g/mL) antibiotic, incubated at 37 ℃ for 14 h. Transfer 500. mu.L into 50mL LB flask while adding Kan+(final concentration 50. mu.g/mL), Cm+(final concentration 50. mu.g/mL), Amp+(final concentration 50. mu.g/mL) resistance, incubation to OD at 37 ℃600Is 0.35. The donor was centrifuged through a 50mL centrifuge tube at 4000rpm for 5min, washed twice with 50mL LB medium, resuspended in 5mL LB medium, and stored at 4 ℃ until use.
Wherein the LB culture medium is prepared by the following method: 10g of peptone, 5g of yeast powder, 5g of sodium chloride and tap water, wherein the volume is constant to 1L, the pH is natural, and the sterilization is carried out at 121 ℃ for 20 min.
B) Preparation of recipient bacterium Streptomyces nodosus
The laboratory strains of Streptomyces nodosus ZJB2016050-Re5 inoculated on GYM plate or slant culture, growing at 28 deg.C for 10d to obtain gray black spores, eluting surface spores to 10mL of 2 XYT culture medium with a cotton stick, filtering the washed spore suspension with a syringe containing cotton, filtering the filtered spores at 12000rpm, centrifuging for 5min, removing supernatant, adding 10mL of 2 XYT culture medium for resuspension, centrifuging at 12000rpm for 5min, eluting again, and finally resuspending with 500. mu.L of 2 XYT culture medium. And thermally shocking the resuspended spores at 50 ℃ for 15-20 min, and keeping the spores at normal temperature for later use.
Wherein the 2 XYT medium is prepared by the following method: 16g of peptone, 10g of yeast powder, 5g of sodium chloride and tap water, wherein the volume is fixed to 1L, the pH is natural, and the sterilization is carried out at 121 ℃ for 20 min.
The preparation method of the GYM solid culture medium comprises the following steps: 4g of glucose, 4g of yeast powder, 10g of malt extract, 2g of calcium carbonate, 18g of agar and tap water with the constant volume of 1L, the pH value of 7.2 and the sterilization at 121 ℃ for 20 min.
C) The process of joining donor and recipient bacteria:
after mixing 500. mu.L of the heat-shocked spore suspension of step B) with 500. mu.L of the donor E.coli suspension of step A), resuspension was performed by centrifugation at 6000rpm for 2min, 800. mu.L of the supernatant was removed, and the pellet was resuspended and spread on a MS solid medium plate containing 10mM magnesium chloride in the remaining supernatant. After culturing at 28 ℃ for 20h, 1mL of aqueous solution containing 0.5mg of napadiramic acid and 0.5mg of thiostrepton antibiotic was applied, and the culture was continued at 28 ℃ for 10 days until transformants appeared.
The transformant was continuously purified 3 times on a solid plate containing naphtholic acid at a final concentration of 50. mu.g/mL and kanamycin-resistant at a final concentration of 50. mu.g/mL until a single colony was obtained, and after PCR verification of the colony of the transformant using 16S RNA upstream and downstream primers (16S-8 and 16S-1541) and M13 upstream and downstream primers (M13(-21) F, M13R), sequencing comparative analysis confirmed that the plasmid (pJTU1278-acc1-acc2-amphA-mcm-mme) had been introduced into the recipient bacterium Streptomyces nodosus ZJB2016050-Re5, and finally the genetically engineered bacterium producing AmB, i.e., the recombinant Streptomyces tuberculatus pJTU 1278-B1-TYB 2, was obtained. Through several rounds of resistance culture, adding Kan+(final concentration 50. mu.g/mL) to obtain the strain Streptomyces nodosus ZJB2016050-De5-pJTU1278-acc1-acc2-amphA-mcm-mme (namely CCTCC NO: M2019341) which is successfully replaced finally.
Wherein the MS solid culture medium is prepared by the following method: 20g of soybean meal, 20g of mannitol, 20g of agar and tap water, wherein the volume is constant to 1L, the pH value is adjusted to 7.2 by sodium hydroxide, and the mixture is sterilized at 121 ℃ for 20 min. Sterile magnesium chloride was added to a final concentration of 10mM before use.
Wherein M13 verifies that the PCR operation is as described in step A).
Wherein the 16sRNA verifies the PCR system: single colonies were picked, 20. mu.L of sterile water was added, and centrifuged at 12000rpm for 1min in a boiling water bath for 30 min. mu.L of the supernatant was used as a template, and 2X Phanta Max Buffer (5. mu.L), dNTP (2.5mM) 0.1. mu.L, 16S forward and reverse primers (0.1. mu.L each), Phanta Max DNA polymerase (0.1. mu.L) and deionized water were added to make up to 10. mu.L.
Among them 16S RNA validation PCR program: denaturation at 98 ℃ for 10s, annealing at 55-60 ℃ for 15s, and extension at 72 ℃ for 1min for 30s for 30 cycles. Finally, extension is carried out for 10min at 72 ℃.
Example 6: shake flask fermentation for producing AmB
(1) Preparation of spore suspension: the AmB-producing recombinant Streptomyces nodosus ZJB2016050-De5-pJTU1278-acc1-acc2-amphA-mcm-mme prepared in example 5 was inoculated into a GYM plate, the plate was cultured at 28 ℃ for 7 days, spores with gray black color were taken, surface spores were eluted into 10mL of sterile water using a cotton swab, the washed spore suspension was filtered by a syringe containing cotton, the filtered spores were centrifuged at 12000rpm for 5min, the supernatant was removed, 10mL of sterile water was added for resuspension, and the filtrate was centrifuged at 12000rpm for 5min and re-eluted once, and 5mL of sterile water was used for resuspension to obtain a spore suspension.
(2) Preparing a seed solution:
inoculating the spore suspension obtained in the step (1) into a seed culture medium, and culturing at 28 ℃ and 220rpm for 46h to obtain a seed solution.
The seed culture medium is prepared by the following method: peptone 20g, NaCl 8g, glucose 15g, yeast powder 10g, CaCO31g, adding water to a constant volume of 1L, adjusting the pH value to 7.0, and sterilizing at 121 ℃ for 20 min.
(3) Fermentation culture
The 500mL standard is shaken and filled with 50mL fermentation medium, the seed liquid is inoculated according to the volume concentration of 2 percent during fermentation, and the fermentation culture is carried out for 168 hours at 28 ℃ and 220 rpm.
The fermentation medium comprises the following components: 70g/L of glucose, 8g/L of beef extract, 8g/L of soybean protein powder, 10g/L of cotton seed powder and CaCO3 10g/L,KH2PO40.2g/L, the solvent is tap water, the pH is 7.0, and the sterilization is carried out for 20min at the temperature of 121 ℃.
The genetically engineered bacteria are produced by shake flask fermentation and detected according to the method of the embodiment 8, wherein the AmB content in the fermentation liquor obtained by ZJB2016050-De5-pJTU1278-acc1-acc2-amphA-mcm-mme is 7.2 g/L.
Example 7: AmB produced by fermentation in 5L fermentation tank
The AmB-producing genetically engineered bacteria (recombinant Streptomyces nodosus ZJB2016050-De5-pJTU1278-acc1-acc2-amphA-mcm-mme) spore suspension or slant culture prepared in example 5 are inoculated into a seed culture medium and cultured at 28 ℃ and 220rpm for 48h to obtain a seed solution.
Fermentation conditions are as follows: 3L of fermentation liquor is filled in a 5L fermentation tank, the inoculation amount is used for inoculating seed liquor according to the volume concentration of 5%, the fermentation culture is carried out for 100h at the temperature of 28 ℃, the pressure of 0.05MPa, the aeration ratio of 1.2vvm and the rotating speed of 400rpm, and fermentation liquor is obtained.
The seed culture medium is prepared by the following method: peptone 20g, NaCl 8g, glucose 15g, yeast powder 10g, CaCO31g, adding water to a constant volume of 1L, adjusting the pH value to 7.0, and sterilizing at 121 ℃ for 20 min.
The fermentation medium of the 5L fermentation tank comprises: 70g/L of glucose, 8g/L of beef extract, 8g/L of soybean protein powder, 10g/L of cotton seed powder and CaCO3 10g/L,KH2PO40.2g/L, the solvent is tap water, the pH is 7.0, and the sterilization is carried out for 20min at the temperature of 121 ℃.
Under the same conditions, the recombinant Streptomyces nodosus ZJB2016050 (namely CCTCC NO: M2017426) is used as a control for fermentation culture.
Comparison of the AmB-producing genetically engineered bacteria (recombinant Streptomyces nodosus ZJB2016050-De5-pJTU1278-acc1-acc2-amphA-mcm-mme) prepared in example 5 with the control bacteria (Streptomyces nodosus ZJB2016050) in a 5L tank fermentation. The genetically engineered bacteria are produced by fermentation in a 5L tank, and the AmB content in the fermentation liquor obtained by the genetically engineered bacteria is 16.0g/L as shown in figure 4 according to the detection method of the embodiment 8, while the yield of the reference strain AmB is 13.6 g/L.
Example 8: preparation of AmB finished product
500L of the fermentation broth obtained in example 7 was taken. Filtering the fermentation liquid with plate frame to obtain wet mycelium, oven drying to obtain dry mycelium weight of 8.1kg, adding the oven dried mycelium into extraction tank, adding 70L methanol, cooling to 4 deg.C, adjusting pH to 3.0 with hydrochloric acid, stabilizing for one hour, and filtering to obtain filtrate. And (3) putting the filtrate into a crystallizing tank, adding 10L of purified water, adjusting the pH to 6.0 by using alkali liquor, heating to 25 ℃, preserving the temperature for one hour, completing crystallization, and standing for layering. Filtering to obtain solid (namely AmB crystal powder), continuously adding methanol for washing, removing impurities, finally drying and crushing to obtain an AmB crude product, wherein the yield of the crude product is 14.6g/L and the product purity is over 94 percent by detecting the crude product through the liquid chromatography described in the embodiment 8.
Example 9: HPLC detection method of AmB
Taking the fermentation liquor prepared by the method of example 5, and mixing the fermentation liquor: DMSO is 1: mixing the mixture with DMSO at the volume ratio of 9, extracting at room temperature for 20-30 minutes, centrifuging at 12000rpm for 5min, taking supernatant, filtering with 0.45 mu m organic filter membrane, and detecting by High Performance Liquid Chromatography (HPLC).
The detection method comprises the following steps: the chromatographic column is C18 column (150 × 4.6mm), the column temperature is 25 deg.C, the flow rate is 1mL/min, the sample volume is 20 μ L, the chromatographic retention time is 30min, and the detection wavelength is 405 nm. The peak time of AmB was 26.9 min.
The preparation method of the mobile phase comprises the following steps: 1.1g EDTA-Na2And 4.1g of sodium acetate, and distilled water are added to the mixture to reach the constant volume of 1L, 900mL of the solution is taken to be mixed with 700mL of acetonitrile and 400mL of methanol, and the pH value of acetic acid is adjusted to 5.0;
AmB yield calculation method: AmB standards were purchased from Sigma, DMSO was used to prepare AmB standards at different concentrations (0mg/L, 200mg/L, 400mg/L, 800mg/L, 1000mg/L), peak areas of the standards were measured by HPLC, and a standard curve was calculated as Y ═ 0.0123X +2539.9, R, from the peak areas and the concentrations of the AmB standards20.999 (where Y is the concentration of AmB and X is the peak area). A peak area can be obtained by detecting an AmB sample with unknown concentration through HPLC, the concentration is obtained by substituting the peak area into the standard curve formula, and the result of the standard curve is shown in FIG. 5.
Sequence listing
<110> Zhejiang industrial university
<120> recombinant streptomyces tuberculatus with high yield of amphotericin B and application thereof
<160> 6
<170> SIPOSequenceListing 1.0
<210> 1
<211> 1776
<212> DNA
<213> Streptomyces nodosus
<400> 1
tcagtccttg atctcgcaga tcgcggcgcc ggaggagagg gaggcgccga cctccgcggt 60
caggcccttg atcgtgccgg ctcggtgcgc gttgagcggc tgctccatct tcatggcctc 120
caggacgacg accaggtcgc cctcctggac ctcctggccc tcctcgaccg cgaccttcac 180
gatcgtgccc tgcatcgggg aggccagggt gtcgccggag accgagggac cggacttctt 240
cgccgcgcgc cgcttcggct tggcgcccgc cgccagaccc gtacgggcca gcgacatacc 300
gagcgacgcg ggcagcgaca cctcgagacg cttgccgccg acctcgacca cgaccgtctc 360
acggcccgcc gggtcctcct cggcctccgc gtccgcggcc gccgcgaacg gcttgatctc 420
gttgacgaac tcggtctcga tccagcgggt gtggaccgtg aaggggccct cggagccggt 480
cagttcgggc gcgaacgcgg tgtccctgac caccgcgcgg tggaacggga tcgccgtggc 540
catcccctcg acctggaact cgtccagggc gcgggcggcc cgctccagag cctccttgcg 600
ggtgcggccc gtcacgatca gcttggccag cagggagtcc cacgccgggc cgatgaccga 660
acccgactcc acacccgcgt ccagccgcac accggggccg gacggcggag cgaacgcggt 720
caccgtgccg ggggcgggca ggaagccccg gcccgggtcc tcgccgttga tccggaactc 780
gaaggaatgg ccgcgcagtt cggggtcgtc atagcccagt tcctcgccgt cggcgatacg 840
gaacatctca cggaccaggt cgatgccggc gacctcctcg gtgaccgggt gctcgacctg 900
gagccgggtg ttgacctcca ggaaggagat cgtcccgtcg ttgccgacca ggaactccac 960
cgtgcccgcg cccacatagc cggcctcctt gaggatggcc ttggacgccg agtacagctc 1020
ggcgacctgc ccgtccgaca ggaacggcgc gggggcctcc tcgaccagct tctggtggcg 1080
ccgctgcagc gagcagtcac gggtggagac caccacgacg ttgccgtgcc ggtcggccag 1140
gcactgtgtc tccacgtgcc ggggccggtc cagatagcgc tccacgaagc actcgccacg 1200
gccgaaggcg gcgaccgcct cacggaccgc cgactcgtac agctcgggga tctcctccag 1260
ggtgcgggcc accttcagac cgcgcccgcc accgccgaag gcggccttga tcgcgatcgg 1320
caggccgtgc tcctcggcga aggtgacgac ctcgtcggcg ccggacaccg ggtcgggcgt 1380
accggcgacc aggggggcac ccgcgcgctg cgcgatgtgc cgggccgcga ccttgtcacc 1440
gagatcgcgg atggcctgcg gcggcgggcc gatccagatc agaccggcgt ccaggacggc 1500
ctgggcgaag tcggcgttct cggagaggaa accgtagccg gggtggatgg cgtccgcgcc 1560
ggaatccttg gccgcctgaa ggaccttgtc gatgtccagg taactggtgg cgggcgtgtc 1620
tcctcccagg gcgaacgcct cgtccgcggc gcggacgtgc agggcgtccc ggtccgggtc 1680
ggcgtagacg gccacgctcg cgatcccggc gtcacgacag gcccgggcga cacggacagc 1740
gatttcgcca cggttggcga tcaacacctt gcgcac 1776
<210> 2
<211> 1941
<212> DNA
<213> Streptomyces nodosus
<400> 2
atgtttgaca cggtgctcgt ggccaaccgg ggcgagatcg cggtccgggt cgtccgcacc 60
ctgcgcgcgc tcggggtgcg ttcggtggcc gtcttctccg acgcggacgc cgacgcccgg 120
cacgtccggg aggccgacac ggcggtacgg atcggaccgg cgcccgcagc cgagagctat 180
ctgtccgtcg agcggctcct cgcggcggcg gcccgcaccg gcgcccaggc ggtgcacccg 240
ggatacggct tcctcgcgga gaacgccgcc ttcgcgaagg cgtgcgcgga ggcggggctg 300
gtcttcatcg ggccgcccgc cgaggcgatc tccctcatgg gcgacaagat ccgcgccaag 360
gagacggtgc gggcggccgg ggtgccggtc gtcccgggct ccgacggcag cgggctgacg 420
gacgagcagc tggccgaggc ggcccacacc atcggcatgc cggtgctgct gaagccgagc 480
gccggcgggg gcggcaaggg catgcggctg gtgcgggagc cggagcggct ggccgaggag 540
atcgccgcgg cccgccgtga ggcccgcgcc tccttcggcg acgacacgct cctggtcgag 600
cgctggatcg accggccccg gcatatcgag atccaggtcc tggccgactc ccacgggaac 660
gtggtgcatc tgggcgagcg cgagtgctcc ctccagcgcc gccaccagaa gctcatcgag 720
gaggcgccca gtgtgttcct cgacgaggcc acccgtgcgg cgatgggcga ggcggcggtc 780
caggcggccc gctcctgcgg ctaccggggc gcgggcacgg tggagttcat cgtcccgggc 840
aacgacccct ccgcctatta cttcatggag atgaacaccc gcctccaggt ggaacacccg 900
gtcaccgagc tggtcaccgg cctggacctg gtggaatggc agctgcgggt ggcggcgggc 960
gagccgctgt ccttcgggca ggacgacatc acgctcaccg ggcacgccgt ggaggcgcgg 1020
atctgcgccg aggaccccgc ccgcggcttc ctcccctccg gcggcacggt gctcgcgctg 1080
cacgaaccgg ggggcgacgg cctccgcacc gactcgggcc tgtccgaggg caccgaggtc 1140
ggcagcctct acgacccgat gctgtccaag gtcatcgccc acggccccga ccgggcgacc 1200
gcgctgcgca gactgcgcgc ggccctcggg gagaccgtca ccctgggcgt ggggaccaac 1260
gccggttttc tgcgccggct gctggcccat cccgcggtcg tggcgggcga actggacacc 1320
gggctggtgg aacgcgaggc ggacggcctc atcccggagg gggtgccgga ggaggtgtac 1380
gaggccgccg ccgccgtgcg cctggacgca ctgcggcccc ggggcgaggg ctggaccgac 1440
ccgttctcgg tgccggacgg ctggcgcctc ggcggcgagc ccgcgcccct gtccttcccc 1500
ctgcgggtgt ccgaaccggt ggagtactcc ccccggggca cccacacggt caccgaggac 1560
cgggtgtccg tggtgctgga cggggtgcgg cacaccttcc accgcgccgc cgactggctc 1620
ggccgggacg gcgacgcctg gcaggtgcgc gaccatgacc cggtcgccgc ctcgctcacc 1680
ggcgccgccc gagccggcac cgactcgctg accgcgccca tgcccggcac ggtcaccgtg 1740
gtgaaggtcg ccgtcgggga cgaggtggcc gcagggcaga gcctgctggt ggtcgaggcg 1800
atgaagatgg agcacgtcat ctccgcgccg cacgccggga ccgtcgccga actcgacgtc 1860
accccgggca ccacggtggt catggaccag gtgctggccg tgatcacccc gcacgaggag 1920
cacacggagg cggagcgatg a 1941
<210> 3
<211> 4239
<212> DNA
<213> Streptomyces nodosus
<400> 3
atgacgatcg gagccaacga cgatccggta gtggtcgtcg gaatggcctg ccgcttcccg 60
ggaggcgtcg aggggcccga ggacctgtgg gagctggtcc gcgacggccg cgacgccacc 120
gggccgttcc ccggcgaccg cggctgggac ctggccgccc tgaccggcga cgggccggac 180
cacagcgtga cccaccgagg cggattcctc gccgcggccg ccgacttcga cgccggcttc 240
ttcgggatgt cgccccgcga ggccgtctcc accgacccgc agcagcggct cgtcctggag 300
acctcctggg aggccctgga acacgccggc atcgacccgc acaccctgcg gggcacccgc 360
accggcgtct tcgtcggcac caacggccag gactacgcga ccgtcaccaa cgcctcccgc 420
gaggacctca ccgggcacgc cctcaccggt ctgtcgccga gcatcgcctc cgggaggctc 480
gcctacttcc tcggcctcga agggcccgcc gtcaccctcg acacggcgtc ctcctcgtcc 540
ctggtcgccc tccactacgc gctgcgctcg ctcaggtcgg gggagtgcac caccgcgctg 600
gccggcggcg tcaccgtgat gtccacaccg gtcgggttca tcgcctacac ccggcagggc 660
ggactcgccg ccgacggccg ctgcaaggtc ttctccgacg acgccgacgg caccacctgg 720
gcggagggcg ccggcatgat cgtgctggag cgcctgtcca ccgcccgcgc cgccgggcac 780
cgggtgctcg ccgtgctgcg cggctccgcc gtcaaccagg acggcgcctc cgacggtctc 840
accgccccca gcggaccggc ccaggaacga ctcgtccgcg aggccctcgc cgacgccgga 900
ctcggacccg ccgacatcga cctcgtcgag gcccacggca ccggcacccg gctcggcgac 960
cccatcgagg cccgggccct gctcgccacc tacggccagg accgcgacgg cggacagccg 1020
ctgcgcctcg gctccctgaa gtccaacatc gggcacgccc aggcagccgc cggcatcggc 1080
ggactcatca aggccgtcca ggcgctgcgc cacggcctga tgccggagac cctgaacctc 1140
tccacgccca cccggcacgt cgactggtcg gccggcgccg tcgaactcct caccgaggcc 1200
ctgccctggc ccggcaccgg ccgcccgcgc cgggccgccg tctcctcctt cggcatcagt 1260
ggcaccaacg cgcatgtcat cgtggaggaa gccccgacga ccgaccccgc cgccgcggtc 1320
cccgccgggc ccgcccaccg ggacgtggcc tcggccgccg actccgccgc gcggcccgct 1380
gccctcgccg gggagcccgc cgacacctct gctcccgccg ctgtcgacgc cggcccggcc 1440
gaccgcccgg tcacccccgc cgctcggctc gccgccctcg tgcccgcggc cgacgccgtc 1500
gcgtggccgg tgtccggggc ctccccggag gctctcgacg cgcaggtcga gcggctcacc 1560
tccttcgtcc gggaccaccc cggcgccgat ccgctggaca tcggtcactc gctggccacc 1620
gggcgggcgg cgttgcggca ccgtgcggtg ctggtgccgt ccggtgacgg tgtcgtggag 1680
atcgcccgcg gtgaggccgc cccccgcacc accgccgtcc tcttctccgg acagggctcc 1740
cagcggctcg gcatgggccg tgaactcgcc gcccgcttcc cggtcttcgc gaaggccctg 1800
gacaccgtcc tggccgccct cgacccccaa ctcgagcgtc cggtgcggtc cgtgatgtgg 1860
ggcgaggacc ccgccgaact cgaccgcacc gggtggaccc agcccgcgct gttcgccttc 1920
gaggtcgccc tgtaccggct cgccgagtcc ttcgggctgc gccccgacgc cgtcggcggc 1980
cactccgtcg gcgagatcgc cgccgcgcac atcgccggag tgctctcgct ggaggacgcc 2040
gcgcgtctgg tcgccgcccg cgccaccctg atgcaggccc tgcccgaggg cggcgccatg 2100
tccgccgtcg aggcctccga ggacgaggtg ctcccgctgc tcgacggcga tgtctcgctc 2160
gccgccgtca acggccccac cgcggtcgtc gtctccggcg ccgaggacgc cgtggagcgc 2220
gtctccgccc acttcgctgc ccaaggccgc cgcaccagcc gcctcgcggt ctcgcacgcc 2280
ttccactcgc cgctgatgga gccgatgctc gacgccttcc gggacgtcgt cgccggactc 2340
accttccatg agccgacgct gccggtgatg tccaacctca ccggtgaact tgccggtgcc 2400
gagatcgcca cccccgagta ctgggtgcgg catgtgcgcg gtaccgtccg cttcgccgac 2460
ggcgtgacgg ccctgcggga acacggcacc gacctgctgg tcgaactggg ccccggcagc 2520
gtcctgaccg ccctcgcccg caccgtcctc ggcccggaca ccccgggcgc ccctgtcgac 2580
gtggtgccca ccctccgcaa ggaccagccc gaggagaggg ctctcaccgc cgcgctcggc 2640
cggctccatg tcctcggcgc gaccgtcgac tggtccgccc tctacaccgg caccggagcc 2700
cgccgcaccg acctgccgac gtacgccttc cagcacgcgc ggtactggcc cgccccgggc 2760
cggcccggca ccggtaccgc gggcggcggg catccgctgc tcggcccggc cgtggaactc 2820
gccgacggcg gcacggtgtc gggcgccaca ctgtccgtcg ccacccaccc ctggctcgcc 2880
gaccatgtcg tcgccgggcg cgtcctgctg cccgccgccg tgctcgtgga actcgccgta 2940
cgcgcgggtg acgacaccgg atgcgacgtc ctgcacgaac tcgccctcgt cgaggcgccg 3000
gtcctggagg ccggcgacac cctggacctc caggtccggg tcggctccgc cgacgaggcc 3060
ggccggcgca ccctcaccgt ccactcccgt cccggcaact cccccgccga gccctggacc 3120
cagcgggccg gcggcctgct cggcaccgcg ccccgcaccg cggcggcccc cgacacctcc 3180
ttcgccgtcg cctggccccc gccgggcgcc gaacccctcg acctcgggga ccactacgag 3240
cggctcgtcg acgacggctt cgacctcggc cccgccttcc gcggtctgcg caccgcctgg 3300
cgccacgacg gcgcgttcct cgccgaggtc gaactcccgg ccggcaccac cgacgacccc 3360
ggcgcctacg gagtgcaccc cgcgctcctc gacgccgccc ggcacgccgc cctcaccacc 3420
accggcacac tcccggtcgc ctggcacggg gtgcggctgc acgccgtcgg cgccaccgcc 3480
ctgcgggtgc ggatccactc cgccgacgac ggtgccctga ccctgaccgc cgccgatgtc 3540
accggcgccc cggtgttcac cgccgaggcc gtcgtcgtac ggcagctcac cgagcaggag 3600
cgcaccgccc cccggccgct cacacgcgcc tggcaccagg acaccgcgac cccgcgccgc 3660
acccggcccg tcgccgcggc ccccggcgcc gccgccgagc cgtccgcctc ctcggcgccg 3720
gacagcttcg ccgccgaggc cgcggccctg gcccccgccg agcgtgaacg ccggctcatc 3780
ggcctggtac ggacccaggc ggcggcggtc ctcggccatc agggcccgga cgcggtcgga 3840
ccccgcgcgg tcttcaagga gctgggcttc gactcgctgg ccggcgtgga actcagtgac 3900
cgcctcaccg cgctcaccgg actgcggctg ccggccaccc tcgtcttcaa cttccccacc 3960
cccgagctcg ccgcccggcg tatcggggaa ctcctcgtcg tatccggctc ctcaccgcag 4020
ggatcgtgcg acgacgaact caccaggttc gaggccgtcg tgcagaccct gtcggccgac 4080
gaccccggac gccaggccgt cgccgaccgc ctggacgcac tcgtcgcctc gctccggcgg 4140
aattccgccc cgcaggagaa cttctccgac gaggacatcg aatcggtgtc ggtcgacaga 4200
ctgctcgaca tcatcgatga agagttcgaa atctcctag 4239
<210> 4
<211> 1737
<212> DNA
<213> Streptomyces nodosus
<400> 4
atggacgctg acgccatcgc ggagggccgc cgacgctggc aggcccgtta tgacgccgca 60
cgcacgcgtg aggcggccgg gggctccgag gcgaaacccc cgaggagctg gacgcgcacc 120
acgctctccg gcgaccccgt ggagcccgtg tacgggcccc ggcccaccga cagctacgag 180
ggcttcgagc ggatcggctg gccgggcgag taccccttca cccgcggtct gtatccgacc 240
ggctaccggg gccggagctg gaccgtccgc cagttcgccg ggttcgggaa cgccgagcag 300
accaatgagc gcttcaaggc gatcctggag gccggcggcg gaggcctgag cgtcgccttc 360
gacatgccga cgctgatggg ccgcgactcc gacgatccgc gctccctggg cgaggtcggg 420
cactgcgggg tggcgatcga ctcggcggcc gacatggagg tcctgttcca ggacatccag 480
ctgggtgagg ttacgacctc gatgacgatc agcggtccgg ccgtccccgt cttctgcatg 540
tatctggtcg ccgccgagcg gcagggcgtc gacccggccg tgctcaacgg cacgctccag 600
accgacatct tcaaggagta catcgcccag aaggagtggc tcttccggcc cgagccgcat 660
ctgcgtctga tcggcgacct gatggagcac tgcacggccg gcatccccgc ctacaagccg 720
ctgtccgtct ccggctacca catccgtgag gcgggcgcga cggccgcaca ggagctggcg 780
tacaccctgg cggacggctt cggatatgtg gagctggggc tcagccgcgg gctcgacgtg 840
gatgtcttcg ccccggggct gtccttcttc ttcgacgcgc atgtcgactt cttcgaggag 900
atcgccaagt tccgggccgc gcgccgcatc tgggcgcgct ggatgcgcga ggtgtacggc 960
gcgcggagcg acaaggcgca gtggctgcgc ttccacaccc agaccgccgg ggtctcgctg 1020
accgcccagc agccgtacaa caacgtggtg cgtacggcgg tggaggcgct ggcggcggtg 1080
ctgggcggga ccaactcgct gcacaccaac gcactggacg agacgctggc gctgccgagc 1140
gaacaggcgg cggagatcgc gctgcgcacc cagcaggtgc tgatggagga gaccggggtc 1200
gcccatgtcg cggacccgct gggcggttcg tggtacgtcg agcagctgac ggaccggatc 1260
gaggcggacg cggagaagat cttcgagcag atcaaggagc ggggactgcg ggcgcatccg 1320
gacggtcggc acccgatcgg cccgatgacc tccggcattc tgcgggggat cgaggacggc 1380
tggttcacgg gcgagatcgc ggagtccgcc ttccgctatc agcaggccct ggagaagggc 1440
gacaagcacg tggtgggcgt caatgtccac accggatcgg tcaccgggga cctggagatc 1500
ctgcgggtcg gccacgaggt ggagcgggag caggtgcggg tgctcgcggc gcgccgggcg 1560
gcgcgggacg agaccgcggt gcgtacggcg ctcgacggca tgctggcggc ggcacgcgac 1620
ggcaccgaca tgatcggccc catgctggac gcggtgcgcg cggaggcgac gctcggcgag 1680
atctgcgggg cgctgcggga cgagtggggg atctacacgg agccgccggg cttctga 1737
<210> 5
<211> 441
<212> DNA
<213> Streptomyces nodosus
<400> 5
atgctgacgc gaatcgacca catcgggatc gcctgcttcg acctggagaa gaccgtcgag 60
ttctacacct cgacctacgg cttctccgtg ttccacaccg agatcaacga ggaacagggc 120
gtccgcgagg ccatgctgaa gatcaatgac acgggcgacg gcggggcctc ctacctccag 180
ctgctggaac ccgtccgcga ggactccgcc gtggcgaagt ggctcgccaa gaacggggag 240
ggcgtacatc acatcgcctt cggcacggcg gacgtcgacg gggacgcgga ggccgtccgg 300
gacaagggcg tgcgcgtgct gtacgacgag ccacgacggg gttccatggg gtcccggatc 360
acctttctgc accccaagga ttgtcacgga gttctcacag aactggtcac atccgcggcc 420
gttgagtcac ctgagcactg a 441
<210> 6
<211> 1227
<212> DNA
<213> Streptomyces nodosus
<400> 6
atgaacgggt ccggcgtccg ggtcgccgtc accgggctgg gcgtcgtcgc ccccaacggc 60
ctgggcgcgg aggcctactg gacggcgacc cgcaagggaa ccagcggcat cggccgcatc 120
tcgcggttcg tccccgacgg gtatccggcc caactggccg gggagatcga gggattcgcc 180
gcggcggagt atctgccggg ccggctgctg ccgcagaccg accggatgac acagctcgcc 240
ctcgtggcag cggactgggc gttcgaggac gccgcggtgc gtcccgggga actgcccgag 300
ttcgagatgg gcgtgatcac ggccagttcc tcgggcggct tcgagttcgg ccagcgggag 360
ttgcaggccc tgtggagcca gggaagccgg tacgtcagcg cgtatcagtc gttcgcctgg 420
ttctacgccg tcaacagcgg ccagatctcc atccgcaacg gcatgcgagg cccgagcggc 480
gtggtcgtca gcgaccaggc cggcggactc gacgcggtcg cccaggcgcg gcgccagatc 540
cgcaagggca cccggctggt gatgtcaggg gccgtggacg cctcgatctg cccctggggc 600
tgggtcgccc agatggcgag caaccggctg agcaccagga ccgacccgga gcgggcgtat 660
ctgcccttcg atgccgcggc gaacggccac gtggccggcg agggcggcgc cctgctcgtc 720
ctggaggaac tggagcaggc ccgagcccgg ggcgcgaagc agatctacgg cgagatcgcc 780
gggtacggct ccacgctcga cccccgcccg ggcagcgagc gtcccgcggg tctgcgcaag 840
gcgatcgaac tggcgctggc cgatgccggg gccacgccgg gcgagatcga cgtggtgttc 900
gccgacgcgg ccgccatccc cgagctggac cggatcgagg ccgcggcgat caacgaggtg 960
ttcggagccg gggcggtgcc ggtgacggcg cccaagacga tgaccgggcg gctctactcg 1020
ggagcggctc ccctggacct ggccgccgcg ttcctcgcca tgcgggacgg ggtgatcccg 1080
ccgtccatcg gcgtcacgcc ctcccccgag cacggcctcg acctggtcgt cgaccaggag 1140
cggaccgcca cagtgcgctc cgccctggtg atcgcccgcg gccacggcgg tttcaactcc 1200
gcaatcgtgg tgcgctccgc cgcatag 1227
Claims (5)
1. Recombinant streptomyces tuberculatus (A) for producing amphotericin BStreptomyces nodosus) And wherein the recombinant Streptomyces nodosus consists of the accession number: CCTCC NO: m2017426 Streptomyces tuberculatus ZJB2016050 knocks out PKS5 gene cluster shown in SEQ ID NO.6, and then introduces acetyl coenzyme A carboxylase 1 gene shown in SEQ ID NO.1, acetyl coenzyme A carboxylase 2 gene shown in SEQ ID NO.2, polyketide synthase PKSamphA gene shown in SEQ ID NO.3, methylmalonyl coenzyme A mutase gene shown in SEQ ID NO.4 and methylmalonyl coenzyme A isomerase gene shown in SEQ ID NO. 5.
2. Use of the recombinant Streptomyces tuberculosus according to claim 1 for the microbial fermentation production of amphotericin B.
3. The use according to claim 2, characterized in that the use is: inoculating the recombinant streptomyces tuberculatus for producing amphotericin B to a fermentation culture medium, carrying out fermentation culture at 25-30 ℃ and 200-500 rpm to obtain fermentation liquor containing amphotericin B, and separating and purifying the fermentation liquor to obtain amphotericin B; the final concentration of the fermentation medium is as follows: 60-80 g/L of glucose, 5-10 g/L of beef extract, 5-10 g/L of soybean protein powder, 8-12 g/L of cotton seed powder and CaCO3 5~10g/L,KH2PO40.1-0.4 g/L, water as solvent, and pH 7.0.
4. The use according to claim 3, characterized in that the fermentation is carried out in a fermenter at a pressure of 0.05MPa and an aeration ratio of 0.08 to 1.5 vvm.
5. The application of claim 3, wherein the recombinant streptomyces tuberculatus producing amphotericin B is subjected to seed culture before fermentation culture, and then a seed solution is inoculated to a fermentation medium in an inoculum size of 2-10% by volume concentration, and the seed culture is as follows: inoculating recombinant streptomyces tuberculatus producing amphotericin B to a GYM plate, culturing at 28 ℃ for 7 days, taking gray and black spores, eluting surface spores into sterile water by using a cotton stick, filtering washed spore suspension by using an injector containing cotton, centrifuging at 12000rpm for 5min, removing supernatant, adding sterile water into a precipitate for re-suspension, centrifuging at 12000rpm for 5min, re-eluting once, re-suspending with sterile water to serve as spore suspension, inoculating the spore suspension into a seed culture medium, and culturing at 28 ℃ and 220rpm for 46h to obtain seed liquid; the final concentration of the GYM plate is as follows: 4g/L of glucose, 4g/L of yeast powder, 10g/L of malt extract, 2g/L of calcium carbonate, 18g/L of agar and water as a solvent, wherein the pH value is 7.2; the final concentration of the seed liquid culture medium is as follows: 10-20 g/L of peptone, 5-10 g/L of NaCl, 10-15 g/L of glucose, 5-10 g/L of yeast powder and CaCO30.5-1 g/L, water as solvent, and pH 7.0.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910451258.6A CN110343650B (en) | 2019-05-28 | 2019-05-28 | Recombinant streptomyces tuberculatus for producing amphotericin B and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910451258.6A CN110343650B (en) | 2019-05-28 | 2019-05-28 | Recombinant streptomyces tuberculatus for producing amphotericin B and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110343650A CN110343650A (en) | 2019-10-18 |
CN110343650B true CN110343650B (en) | 2020-12-29 |
Family
ID=68173984
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910451258.6A Active CN110343650B (en) | 2019-05-28 | 2019-05-28 | Recombinant streptomyces tuberculatus for producing amphotericin B and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110343650B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113832089B (en) * | 2021-09-10 | 2023-08-25 | 浙江工业大学 | Recombinant streptomyces node for high-yield amphotericin B, construction method and application |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1328466A (en) * | 1998-10-27 | 2001-12-26 | 坎迪塔医药有限公司 | Use of antifungal agents for treating scleroses |
RU2198928C2 (en) * | 2000-12-13 | 2003-02-20 | Общество с ограниченной ответственностью "Элест" | Strain streptomyces nodosus 472 vniischm d-666 as producer of amphotericin b |
WO2002097082A8 (en) * | 2001-05-31 | 2004-04-29 | Univ Dublin | Engineered biosynthesis of novel polyenes |
CN102382158A (en) * | 2010-09-06 | 2012-03-21 | 华北制药集团新药研究开发有限责任公司 | Preparation method of high-purity amphotericin B |
CN105524961A (en) * | 2016-02-23 | 2016-04-27 | 华北制药集团新药研究开发有限责任公司 | Method for producing amphotericin B through fermentation |
EP3025733A1 (en) * | 2013-07-25 | 2016-06-01 | Beijing Labworld Bio-medicine Technology Corp. Ltd. | Pharmaceutical, water-soluble and antifungal macromolecular compound |
CN107893048A (en) * | 2017-10-17 | 2018-04-10 | 浙江工业大学 | A kind of restructuring streptomyces nodocus for producing amphotericin B and its application |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR0105500A (en) * | 2001-11-05 | 2004-06-22 | Univ Minas Gerais | Process for obtaining colloidal dispersions of amphotericin b; amphotericin b based compositions for enteral, parenteral and topical use; use of these compositions in the treatment of systemic mycoses and parasitic infections |
EP1625225A1 (en) * | 2003-05-22 | 2006-02-15 | DSM IP Assets B.V. | Autoinducer compound to improve the productivity of natamycin producing streptomyces strains |
CN100348727C (en) * | 2005-03-08 | 2007-11-14 | 华中农业大学 | Method for increasing yield of streptomycete antibiotic and the strain thereof |
US9080199B2 (en) * | 2010-10-29 | 2015-07-14 | The Regents Of The University Of California | Method to generate novel bioactive molecules |
UA123760C2 (en) * | 2011-11-11 | 2021-06-02 | Гіліад Аполло, Ллс | COMPOUND (OPTIONS) AND COMPOSITION CONTAINING COMPOUND |
WO2014182951A1 (en) * | 2013-05-10 | 2014-11-13 | Nimbus Apollo, Inc. | Acc inhibitors and uses thereof |
CN108441459B (en) * | 2018-02-12 | 2020-02-14 | 浙江工业大学 | Recombinant streptomyces tuberculatus capable of producing amphotericin B at high yield and application thereof |
CN109762752B (en) * | 2018-11-01 | 2020-06-30 | 福建省农业科学院植物保护研究所 | Streptomyces nodulicidal strain and application thereof |
-
2019
- 2019-05-28 CN CN201910451258.6A patent/CN110343650B/en active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1328466A (en) * | 1998-10-27 | 2001-12-26 | 坎迪塔医药有限公司 | Use of antifungal agents for treating scleroses |
RU2198928C2 (en) * | 2000-12-13 | 2003-02-20 | Общество с ограниченной ответственностью "Элест" | Strain streptomyces nodosus 472 vniischm d-666 as producer of amphotericin b |
WO2002097082A8 (en) * | 2001-05-31 | 2004-04-29 | Univ Dublin | Engineered biosynthesis of novel polyenes |
CN102382158A (en) * | 2010-09-06 | 2012-03-21 | 华北制药集团新药研究开发有限责任公司 | Preparation method of high-purity amphotericin B |
EP3025733A1 (en) * | 2013-07-25 | 2016-06-01 | Beijing Labworld Bio-medicine Technology Corp. Ltd. | Pharmaceutical, water-soluble and antifungal macromolecular compound |
CN105524961A (en) * | 2016-02-23 | 2016-04-27 | 华北制药集团新药研究开发有限责任公司 | Method for producing amphotericin B through fermentation |
CN107893048A (en) * | 2017-10-17 | 2018-04-10 | 浙江工业大学 | A kind of restructuring streptomyces nodocus for producing amphotericin B and its application |
Non-Patent Citations (2)
Title |
---|
HARALD A.B. 等.Production of amphotericin B-14C by streptomyces nodosus fermentation,and preparation pf the amphotericin B-14C-methyl-ester.《THE JOURNAL OF ANTIBIOTICS》.1974,第27卷(第3期), * |
两性霉素B 生产菌培养基成分及发酵条件;张博 等;《科技导报》;20161228(第24期);第87-92页 * |
Also Published As
Publication number | Publication date |
---|---|
CN110343650A (en) | 2019-10-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112195110B (en) | Recombinant aspergillus oryzae strain and kojic acid fermentation method and application thereof | |
CN110157654B (en) | Bacillus natto recombinant strain and construction method and application thereof | |
CN108441459B (en) | Recombinant streptomyces tuberculatus capable of producing amphotericin B at high yield and application thereof | |
CN104762247A (en) | A genetic engineering strain for increasing the yield of ascomycin and a constructing method | |
KR101542243B1 (en) | Genetically engineered strain wsj-ia for producing isovaleryl spiramycin i | |
CN108753674B (en) | Gene cluster for regulating and controlling milbemycin synthesis, recombinant streptomycete, and preparation method and application thereof | |
CN113637619B (en) | Saccharopolyspora spinosa delta Clu13-MmsA and construction method and application thereof | |
CN110564718B (en) | Method and strain for screening high-yield amphotericin B-tubercle streptomycete by high-throughput mutagenesis | |
CN110343650B (en) | Recombinant streptomyces tuberculatus for producing amphotericin B and application thereof | |
CN111197020B (en) | Recombinant bacterium for producing milbemycins as well as construction method and application thereof | |
CN103834605B (en) | A kind of Abamectin producing bacterium and its preparation method and application | |
CN110577921B (en) | Recombinant streptomyces tuberculatus for producing amphotericin B and application thereof | |
CN108660101B (en) | Recombinant microorganism expressing ivermectin B, preparation method and application thereof | |
CN113462628B (en) | Gene engineering bacterium for producing heme as well as construction method and application thereof | |
CN102719388A (en) | Method for improving yield of streptomyces antibiotics and plasmids thereof | |
CN110305881B (en) | Biosynthetic gene cluster of polyketide neoenterocins and application thereof | |
CN106554932B (en) | Genencor engineering bacterium for producing gentamicin B and construction method thereof | |
CN110423790B (en) | Metabolic engineering method for directionally producing high yield antifungal tetramycin B | |
CN113801834A (en) | Gene engineering streptomyces diastatochromogenes with high yield of toyocamycin and construction method and application thereof | |
CN112409372A (en) | Rubicin analogue, preparation method and application thereof | |
CN114150006B (en) | Gene cluster and recombinant bacterium capable of improving milbemycins yield and preparation method and application thereof | |
CN114717281B (en) | Method for improving fermentation yield of heterologous spinosad expression strain by optimizing carbon source | |
CN110408643B (en) | Method for improving yield of streptomyces autolyzed oleanolic acid and derivatives thereof | |
CN117286203A (en) | Method for improving avermectin yield by expressing rhodosporidium saccharopolyspora mms operon | |
CN114763553B (en) | Recombinant vector for improving yield of macrolide antibiotics, recombinant bacterium and application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |